Å‹ß‚ÌŠw‰ï”­•\i”²ˆj

2025

14) ”öèœ, ’†o—F”ü, ŽR“c‘א¬, ŠÖŒû–ƒ—I, œA£P‹v, ì£‹M”Ž, ’Ò ˆ€, ‘q‰iŒ’Žj, Š|’JGº, —F‰iÈŽO, ‰ºŠÔŽuŽm. PBrƒJƒ‰ƒ€‚ƃ‰ƒxƒ‹‰»ÜL-FDLDA‚ð—p‚¢‚œ“®•šŽí‚̈قȂéH“÷’†‚̃Cƒ~ƒ_ƒ][ƒ‹ƒWƒyƒvƒ`ƒh‚ÆŠÖ˜A‰»‡•š‚Ì’è—Ê•ªÍ–@‚ÌŠm—§. ‘æ79‰ñ“ú–{‰h—{EH—ÆŠw‰ï‘å‰ï, ˆ€’m, 5ŒŽ, 2025. @
13) ŽR“c‘א¬, ”öè œ, œA£P‹v, ’r“c–Ÿ‰Ä—¢, ‘q‰iŒ’Žj,@Š|’JGº, ‰ºŠÔŽuŽm. ‚ŠŽ“x—U“±‘̉»ŽŽ–òD-FDLDA‚ð—p‚¢‚œ“¯ˆÊ‘Ì•WŽ¯—U“±‘̉»–@‚É‚æ‚鐶‘̃Aƒ~ƒ“‚š‚æ‚Ñ‘O‹ì‘̃Aƒ~ƒmŽ_‚Ì’è—Ê. ‘æ79‰ñ“ú–{‰h—{EH—ÆŠw‰ï‘å‰ï, ˆ€’m, 5ŒŽ, 2025. @
12) Š|’JGº. “ú–{–òŠw‰ïÜEŽóÜu‰‰F‘n–ò‚ðŽuŒü‚µ‚œ“V‘R•šƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[Œ€‹†. “ú–{–òŠw‰ï‘æ145”N‰ïi•Ÿ‰ªj, •Ÿ‰ª, 3ŒŽ, 2025. iŽóÜu‰‰j@
11) Š|’JGº. ƒVƒ“ƒ|ƒWƒEƒ€uƒ‚ƒmƒgƒŠƒTƒCƒGƒ“ƒX@ƒAƒbƒvƒgƒDƒfƒCƒgvFhƒ‚ƒmƒgƒŠh‚ðŠî”Õ‚Æ‚µ‚œ“V‘R•š‘n–òƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[. “ú–{–òŠw‰ï‘æ145”N‰ïi•Ÿ‰ªj, •Ÿ‰ª, 3ŒŽ, 2025. iµ‘ҍu‰‰j@
10) ŽO‘º@•Ò, ’r“c‘ñŒd, ŽÄèŽçO, Žü–h‘åŽ÷, ‹Ž–{ˆºŽq, V‰Æˆê’j, ˆä–{³Æ, Š|’JGº. V‹K‚ª‚ñŠ²×–EƒXƒtƒFƒAŒ`¬‘jŠQÜƒXƒgƒŒƒvƒgƒXƒtƒFƒŠƒ“A‚̐¶ŽY«Œüã‚ƐV‹K—Þ‰‘Ì‚Ì”­Œ©. “ú–{–òŠw‰ï‘æ145”N‰ïi•Ÿ‰ªj, •Ÿ‰ª, 3ŒŽ, 2025.
9) úåàV˜aŠó, ‹àŽqŒ«‰î, ’r“c‘ñŒd, Šâ“cƒ‰À, ‘º’†ŒúÆ, ‰z–ìLá, ’·”ö–ì‰f‰Ô, “n i, Œ‘ºTˆê, V—¢®–ç, ”ö’‡GN, Š|’JGº. •úü‹Û‚Ì•¡‡”|—{‚É‚æ‚èŽY¶‚³‚ê‚éV‹Kƒsƒ‰ƒmƒiƒtƒgƒLƒmƒ“Œn‰»‡•š‚Ì’P—£E\‘¢‰ðÍ‚Æ‚»‚ÌŽY¶‚ÉŠÖ‚·‚錀‹†. “ú–{–òŠw‰ï‘æ145”N‰ïi•Ÿ‰ªj, •Ÿ‰ª, 3ŒŽ, 2025.
8) Zhang, L., Pan, Y., •ž•” –Ÿ, A‘G—T, •œ–ìG“T, Š|’JGº. ^‹ÛStachybotrys‘®‚ª¶ŽY‚·‚éV‹K‹€—LŒ‹‡«ƒAƒXƒpƒ‰ƒMƒ“‡¬y‘f‘jŠQÜ‚ÌŠJ”­Œ€‹†. “ú–{–òŠw‰ï‘æ145”N‰ïi•Ÿ‰ªj, •Ÿ‰ª, 3ŒŽ, 2025.
7) Œˆä”ü—RŠó, ’r“c‘ñŒd, ŽÄèŽçO, âˆä˜aŽq, Œ”ö˜al, ˆä–{³Æ, Š|’JGº. ‚ª‚ñŠ²×–EƒXƒtƒFƒAŒ`¬‘jŠQŠˆ«‚ð—L‚·‚é•úü‹Û‘ãŽÓŽY•š‚Ì”­Œ©‚ƍì—p‹@˜‰ðÍ. “ú–{–òŠw‰ï‘æ145”N‰ïi•Ÿ‰ªj, •Ÿ‰ª, 3ŒŽ, 2025.@
6) ’r“c‘ñŒd, ˆä‰§Œå, “¡–{ØXŽq, ¬—ѐŽ, “ü]ˆê_, ŒŽ“c _, Š|’JGº. ‹•ŒŒ«ŽŸŠ³Ž¡—Âɂš‚¯‚éPKCƒ¿/mTORCƒVƒOƒiƒ‹‚ð‰î‚µ‚œHIF-1ƒ¿Šˆ«‰»í—ª. “ú–{–òŠw‰ï‘æ145”N‰ïi•Ÿ‰ªj, •Ÿ‰ª, 3ŒŽ, 2025.@
5) “n i, ‹Ž–{ œ, Îì˜aŽ÷, ŒF–{‘ìÆ, Š|’JGº, Žs£_Žu. ƒAƒNƒ`ƒmƒƒWƒ“¶‡¬‚ÉŠÖ—^‚·‚éV‹KŽ_‰»y‘fActVA-ORF3‚ÌAlphaFold‚ð—˜—p‚µ‚œ‹@”\‰ðÍŒ€‹†. “ú–{–òŠw‰ï‘æ145”N‰ïi•Ÿ‰ªj, •Ÿ‰ª, 3ŒŽ, 2025.@
4) ‰ª–{«Žj, X“c‘å•ã, H—tGŽ÷, •ž•” –Ÿ —L’n–@l, Š|’JGº, ‘å–ì_Í, ˆäŠÑW•ã. Ž‰Ž¿‚ŒŽ’ñŽŠƒ^ƒ“ƒpƒNŽ¿CD1a‚É”FŽ¯‚³‚ê‚郊ƒ|ƒyƒvƒ`ƒhDDM-838‚̍\‘¢Šˆ«‘ŠŠÖŒ€‹†. “ú–{–òŠw‰ï‘æ145”N‰ïi•Ÿ‰ªj, •Ÿ‰ª, 3ŒŽ, 2025.@
3) Kakeya, H. Natural product-inspired chemical biology: Development of an agrochemical seed targeting the scab-forming actinomycete. Asian Chemical Biology Initiative (ACBI) 2025 Hanoi Meeting, Hanoi, Vietnam, Jan. 2025. (invited)
2) Kakeya, H. Natural product-inspired chemical biology: Development of highly sensitive labeling reagents for amino acids, scarce natural products, and amylooid beta fragment peptides. The 5th Intenational Conference on Natural Product Discovery and Development in the Genomic Era. San Diego, CA, USA, Jan. 2025.
1) Yanagisawa, K., Kaneko, K., Ikeda, H., Iwata, S., Muranaka, A., Koshino, H., Nagao, N., Watari, S., Nishimura, S., Shinzato, N., Onaka, H., Kakeya, H. Discovery of a new pyranonaphthoquinone, actinoquinonal A: Combined-culture of Streptomyces sp. 23-50 with Tsukamurella pulmonis TP-B0596 triggers a shunt of the mevalonate pathway of Streptomyces sp. 23-50. The 5th Intenational Conference on Natural Product Discovery and Development in the Genomic Era. San Diego, CA, USA, Jan. 2025. [—DG”­•\Üiƒ|ƒXƒ^[”­•\)FThe Carol D. Litchfield Honorable Mention Student Poster Presentation]

2024

33) ”öèœ, ’†o—F”ü, ŠÖŒû–ƒ—I, œA£P‹v, ì£‹M”Ž, ’Ò ˆ€, ‘q‰iŒ’Žj, Š|’JGº, —F‰iÈŽO, ‰ºŠÔŽuŽm. PBrƒJƒ‰ƒ€‚ƃ‰ƒxƒ‹‰»ÜL-FDLDA‚ð—p‚¢‚œH“÷’†‚̃Cƒ~ƒ_ƒ][ƒ‹ƒWƒyƒvƒ`ƒh‚ÆŠÖ˜A‰»‡•š‚Ì’è—Ê. ‘æ14‰ñVƒAƒ~ƒmŽ_•ªÍŒ€‹†‰ï, “Œ‹ž, 12ŒŽ, 2024. @
32) ŽR“c‘א¬, ”öè œ, œA£P‹v, ’r“c–Ÿ‰Ä—¢, ‘q‰iŒ’Žj,@Š|’JGº, ‰ºŠÔŽuŽm. ‚ŠŽ“xƒ‰ƒxƒ‹‰»ÜD-FDLDA‚ð—p‚¢‚œƒr[ƒ‹’†‚̐¶‘̃Aƒ~ƒ“—Þ‚š‚æ‚ÑŠÖ˜A‰»‡•š‚̈êÄ•ªÍ. ‘æ14‰ñVƒAƒ~ƒmŽ_•ªÍŒ€‹†‰ï, “Œ‹ž, 12ŒŽ, 2024. @
31) Žü–h‘åŽ÷, ‘q‰iŒ’Žj, ‹g“c¹ˆ», ¬ŽR ˆ€, ’r“c‘ñŒd, ŽÄèŽçO, Š|’JGº. V‹K‚ª‚ñŠ²×–EƒXƒtƒFƒAŒ`¬‘jŠQÜƒXƒgƒŒƒvƒgƒXƒtƒFƒŠƒ“A‚̍\‘¢Œˆ’è‹y‚Ñ‘S‡¬Œ€‹†. ‘æ41‰ñƒƒfƒBƒVƒiƒ‹ƒPƒ~ƒXƒgƒŠ[ƒVƒ“ƒ|ƒWƒEƒ€, ‹ž“s, 11ŒŽ, 2024.
30) ‰ª–{«Žj, X“c‘å•ã, H—tGŽ÷, •ž•” –Ÿ —L’n–@l, Š|’JGº, ‘å–ì_Í, ˆäŠÑW•ã. CD1aS‘©«T×–E‚𐧌䂷‚錋Šj‹Û—R—ˆƒŠƒ|ƒyƒvƒ`ƒhDDM-838‚̍\‘¢Šˆ«‘ŠŠÖŒ€‹†. ‘æ41‰ñƒƒfƒBƒVƒiƒ‹ƒPƒ~ƒXƒgƒŠ[ƒVƒ“ƒ|ƒWƒEƒ€, ‹ž“s, 11ŒŽ, 2024.
29) Zhang, L., Pan, Y., Hattori, A., Uekusa, H., Kakeya, H.Discovery of new meroterpenoids produced by Stachybotrys ruwenzoriensis RF-6853 as asparagine synthetase inhibitors. Seoul Univ.-Kyoto Univ.-Osaka Univ. Symposium 2024 (SKO Symposium 2024). Seoul, Korea, Nov., 2024.
28) ŽR“c‘א¬, ”öèœ, ‰ºŠÔŽuŽm, ’r“c–Ÿ‰Ä—¢, ‘q‰iŒ’Žj, Š|’JGº, œA£P‹v. ‚ŠŽ“xƒ‰ƒxƒ‹‰»ÜD-FDLDA‚ð—p‚¢‚œƒr[ƒ‹’†‚Ì•…”sƒAƒ~ƒ“—Þ‚š‚æ‚ÑŠÖ˜A‰»‡•š‚̈êÄ•ªÍ. ‘æ120‰ñ“ú–{H•i‰q¶Šw‰ïŠwpu‰‰‰ï, ˆ€’m, 11ŒŽ, 2024.
27) ”öèœ, ’†o—F”ü, ŠÖŒû–ƒ—I, ‰ºŠÔŽuŽm, ì£‹M”Ž, ’Ò ˆ€, ‘q‰iŒ’Žj, Š|’JGº, —F‰iÈŽO,@œA£P‹v. ƒ‰ƒxƒ‹‰»ÜL-FDVDA‚ÆPBrƒJƒ‰ƒ€‚ð—p‚¢‚œ“®•šŽíE‘gDE•iŽí‚̈قȂéH“÷’†‚̃Cƒ~ƒ_ƒ][ƒ‹ƒWƒyƒvƒ`ƒh‚ƍ\¬ƒAƒ~ƒmŽ_Aƒ^ƒEƒŠƒ“‚Ì’è—Ê•ªÍ. ‘æ120‰ñ“ú–{H•i‰q¶Šw‰ïŠwpu‰‰‰ï, ˆ€’m, 11ŒŽ, 2024.
26) ”öèœ, ’†o—F”ü, ’r“c–Ÿ‰Ä—¢, ‘q‰iŒ’Žj, Š|’JGº, œA£P‹v. ‚ŠŽ“xŒõŠw•ªŠ„ƒ‰ƒxƒ‹‰»ÜL-FDLDA‚ð—p‚¢‚œ”­yH•iEˆù—¿’†‚ÌDL-ƒAƒ~ƒmŽ_‚Ì’è—Ê•ªÍ–@‚ÌŠJ”­. ‘æ120‰ñ“ú–{H•i‰q¶Šw‰ïŠwpu‰‰‰ï, ˆ€’m, 11ŒŽ, 2024.
25) Kakeya, H., Pan, Y., Zhang, L., Suzuki, T., Sakai, K., Hirano, Y., Ikeda, H., Hattori, A., Dohmae, N., Nishio, K. Identification and a mode of action of bisabosqual A, a novel asparaginase synthetase (ASNS) inhibitor, towards the development of molecular-targeted anticancer drug. 36th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics. Barcelona, Spain, Oct. 2024. (EORTC, the European Organization for Research and Treatment of Cancer; NCI, the National Cancer Institute; AACR, the American Association for Cancer Research)
24) úåàV˜aŠó, ‹àŽqŒ«‰î, ’r“c‘ñŒd, Šâ“cƒ‰À, ‘º’†ŒúÆ, ‰z–ìLá, ’·”ö–ì‰f‰Ô, “n i, Œ‘ºTˆê, V—¢®–ç, ”ö’‡GN, Š|’JGº. •úü‹Û‚Ì•¡‡”|—{‚ƃƒ^ƒ{ƒ[ƒ€‰ðÍ‚É‚æ‚éV‹KR‚ª‚ñÜƒV[ƒY‚ÌŠJ”­Œ€‹†. ‘æ74‰ñ“ú–{–òŠw‰ïŠÖŒŽx•”‘‰ïE‘å‰ï, •ºŒÉ, 10ŒŽ, 2024.[—DGÜ]@@
23) ’r“c‘ñŒd, ìŒ©”ü—¢, ŽÄèŽçO, ŽO‘º •Ò, Š|’JGº. ‚ª‚ñŠ²×–E‚ð•W“I‚Æ‚·‚é”÷¶•š“ñŽŸ‘ãŽÓŽY•š‚Ì”­Œ©‚ƍì—p‹@˜‰ðÍ. ‘æ74‰ñ“ú–{–òŠw‰ïŠÖŒŽx•”‘‰ïE‘å‰ï, •ºŒÉ, 10ŒŽ, 2024.@
22) ¬ŽR ˆ€, ‘q‰iŒ’Žj, X–{—Á‘Ÿ, ŒŒ³‘ñŠC, Š|’JGº. ‚Ë‚¶‚êŒ^ƒAƒ~ƒh‚ð‰î‚µ‚œƒyƒvƒ`ƒh‡¬–@‚ÌŠJ”­‚Æ’†•ªŽqŠÂóƒyƒvƒ`ƒh‡¬‚ւ̉ž—p. ‘æ74‰ñ“ú–{–òŠw‰ïŠÖŒŽx•”‘‰ïE‘å‰ï, •ºŒÉ, 10ŒŽ, 2024. [—DGÜ]@
21) Ikeda, H., Iseki, S., Kobayashi, S., Irie, K., Harada, H., Kakeya, H. Upregulation of HIF-1ƒ¿ via the PKCƒ¿/mTORC signaling pathway is a potential therapeutic strategy for ishemia-related diseases. The 4th network salon, Medical Innovation Program, Kyoto University, Kyoto, Sep. 2023.
20) Furutani, Y., Tanaka, K., Nagamori, S., Kobayashi, K., Aizaki, H., Ochi, S., Kakeya, H., Matsuura, T. Development of cccDNA modulators, CDMs, that specifically activate interferon-related signals and inhibit HBV replication. 2024 International HBV Meeting: Biology of the Hepatitis B and Viruses. Chicago, IL, USA, Sep. 2024@
19) ”öèœ, ’†o—F”ü, ŠÖŒû–ƒ—I, ‰ºŠÔŽuŽm, ì£‹M”Ž, ’Ò ˆ€, ‘q‰iŒ’Žj, Š|’JGº, —F‰iÈŽO,@œA£P‹v. ƒ‰ƒxƒ‹‰»ÜL-FDVDA‚ÆPBrƒJƒ‰ƒ€‚ð—p‚¢‚œ“®•šŽíE‘gDE•iŽí‚̈قȂéH“÷’†‚̃Cƒ~ƒ_ƒ][ƒ‹ƒWƒyƒvƒ`ƒh‚ƍ\¬ƒAƒ~ƒmŽ_Aƒ^ƒEƒŠƒ“‚̈êÄ•ªÍ. “ú–{ƒAƒ~ƒmŽ_Šw‰ï‘æ18‰ñŠwp‘å‰ïiJSAAS2024j, é‹Ê, 9ŒŽ, 2024.
18) “¿“c“V¬, ’r“c‘ñŒd, ‘q‰iŒ’Žj, –¥Žè–œ—R—¢, àN³Œª, ’JŒû“§, V—¢®–ç, ”ö’‡GN, Š|’JGº. V‹KƒAƒmƒCƒLƒX—U“±ÜƒAƒ‚ƒLƒZƒ^ƒ~ƒhA‚Ì’P—£E\‘¢‰ðÍ‹y‚Ñ‘S‡¬. ‘æ66‰ñ“V‘R—L‹@‰»‡•š“¢˜_‰ï, ‹ž“s, 9ŒŽ, 2024.
17) ‹àŽqŒ«‰î, ŽOŽ}Ÿ{‰Ô, Yulu Jiang, ‚‹ŽL–Ÿ, Š|’JGº. A•š•aŠQ‚»‚€‚©•aŒŽˆö‹Û‚ð•W“I‚Æ‚·‚é”_–òƒV[ƒYŠJ”­Œ€‹†FƒcƒƒZƒiƒ~ƒhC‚Ì”­Œ©‚ƍì—p‹@˜‰ðÍ. ‘æ66‰ñ“V‘R—L‹@‰»‡•š“¢˜_‰ï, ‹ž“s, 9ŒŽ, 2024.
16) Kakeya, H. Natural product-inspired chemical biology: Development of highly sensitive labeling reagents for amino acids and scarce natural products. International Congress on Natural Products Research 2024 (ICNPR 2024), Krakow, Poland, Jul. 2024.@@
15) úåàV˜aŠó, ‹àŽqŒ«‰î, ’r“c‘ñŒd, Šâ“cƒ‰À, ‘º’†ŒúÆ, ‰z–ìLá, ’·”ö–ì‰f‰Ô, “n i, Œ‘ºTˆê, V—¢®–ç, ”ö’‡GN, Š|’JGº. •úü‹Û‚Ì•¡‡”|—{‚É‚æ‚éV‹KR‚ª‚ñÜƒV[ƒY‚ÌŠJ”­Œ€‹†. ‘æ34‰ñV–ò‘n»’k˜b‰ï, “È–Ø, 7ŒŽ, 2024. [Œ€‹†§—ãÜ]@@@
14) ’r“c‘ñŒd, ˆä–{³Æ, Š|’JGº. ‚ª‚ñŠ²×–E‚ð•W“I‚Æ‚·‚郌ƒmƒŒƒ}ƒCƒVƒ“‚Ì“¯’èEì—p‹@˜. ‘æ28‰ñ“ú–{‚ª‚ñ•ªŽq•W“IŽ¡—Êw‰ï, “Œ‹ž, 6ŒŽ, 2024.@@
13) Furutani, Y., Kakeya, H., Matsuura, T. Development of novel small molecules that activate innate immunity and inhibit HBV replication. The 60th Annual Meeting of the Japan Society of Hepatology, Kumamoto, Jun, 2024.
12) ‹àŽqŒ«‰î, ŽOŽ}Ÿ{‰Ô, Yulu Jiang, ‚‹ŽL–Ÿ, Š|’JGº. •úü‹Û‘ãŽÓŽY•šƒcƒƒZƒiƒ~ƒhC‚̍R‚»‚€‚©•aŒŽˆö‹ÛŠˆ«‚Æ‚»‚̑ϐ«‰»‚ª‚à‚œ‚ç‚·ƒ†ƒj[ƒN‚È•\Œ»Œ^‚ɂ‚¢‚Ä. “ú–{ƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[Šw‰ï@‘æ18‰ñ”N‰ï, “Œ‹ž, 5ŒŽ, 2024.
11) Kakeya, H. Separation and identification of the D/L-forms of amino acids and short-chain peptides using highly sensitive labeling reagents for research of cardiovascular disease. The 9th Annual Scientific Meeting of JCVA (Japan Cardiovascular Association), Shizuoka, May 2024.
10) ”öè œ, ’†o—F”ü, ‰ºŠÔŽuŽm, ì£‹M”Ž, ’ҁ@ˆ€, ‘q‰iŒ’Žj, Š|’JGº, —F‰iÈŽO, œA£P‹v. ‚ŠŽ“xƒ‰ƒxƒ‹‰»ÜL-FDVDA‚ÆPBrƒJƒ‰ƒ€‚ð—p‚¢‚œH•i’†‚̃Cƒ~ƒ_ƒ][ƒ‹ƒWƒyƒvƒ`ƒh‚ƍ\¬ƒAƒ~ƒmŽ_Aƒ^ƒEƒŠƒ“‚̈êÄ•ªÍ. ‘æ78‰ñ“ú–{‰h—{EH—ÆŠw‰ï‘å‰ï, •Ÿ‰ª, 5ŒŽ, 2024.
9) ŠÝ–{[O, ¬Œ©ŽR–ƒ‹I, ˜a“cŒ[“¹, óŒŽ“NŽq, ŽR‰Aˆê, ”öè—T, ÂŽRLŽ÷, Ÿ‰Y•ÛG, ¡òŒú, ‹Ž–{³, »ì—zˆê, X–{’B–ç, ‹àˆä‰ëŽj, Š|’JGº, ’·’Jì_“ñ. –³ÇóEŒyÇ‚̐VŒ^ƒRƒƒiƒEƒCƒ‹ƒXŠŽõÇŠ³ŽÒ‚É‚š‚¯‚éŒoŒû‚‹zŽûƒNƒ‹ƒNƒ~ƒ“iƒNƒ‹ƒNƒ‹[ƒWƒ…j‚Ì’†“™Ç‚ւ̐i“W—}§Œø‰Ê‚ðŒŸØ‚·‚éƒvƒ‰ƒZƒ{‘ΏƓñd–ÓŒŸ–³ìˆ×‰»”äŠrŽŽŒ±. “ú–{–òŠw‰ï‘æ144”N‰ïi‰¡•lj, ‰¡•l, 3ŒŽ, 2024.@@
8) Žü–h‘åŽ÷, ‘q‰iŒ’Žj, ‹g“c¹ˆ», ’r“c‘ñŒd, ŽÄèŽçO, Š|’JGº. V‹K‚ª‚ñŠ²×–EƒXƒtƒFƒAŒ`¬‘jŠQÜƒXƒgƒŒƒvƒgƒXƒtƒFƒŠƒ“A‚Ì‘S‡¬Œ€‹†. “ú–{–òŠw‰ï‘æ144”N‰ïi‰¡•lj, ‰¡•l, 3ŒŽ, 2024.
7) “¿“c“V¬, ‘q‰iŒ’Žj, –¥Žè–œ—R—¢, ’r“c‘ñŒd, àN³Œª, Š|’JGº. V‹KƒAƒmƒCƒLƒX—U“±ÜƒAƒ‚ƒLƒZƒ^ƒ~ƒhA‚ÌŠ®‘S\‘¢Œˆ’è‹y‚Ñ‘S‡¬Œ€‹†. “ú–{–òŠw‰ï‘æ144”N‰ïi‰¡•lj, ‰¡•l, 3ŒŽ, 2024.
6) à“c•®, ‘q‰iŒ’Žj, ’ç—œ‘Ÿ˜Y, Š|’JGº. V‹KR^‹ÛÜƒAƒ€ƒtƒBƒI[ƒ‹‚Ì‘S‡¬Œ€‹†. “ú–{–òŠw‰ï‘æ144”N‰ïi‰¡•lj, ‰¡•l, 3ŒŽ, 2024.
5) ’r“c‘ñŒd, ŽÄèŽçO, Šª“cÊ‹G, ‘DŽR‰À‘ã, Žü–h‘åŽ÷, ‹g“c¹ˆ», ‘q‰iŒ’Žj, V“¡ˆê•q, ~Šøˆê•v, ˆä–{³Æ, Š|’JGº. V‹K‚ª‚ñŠ²×–EƒXƒtƒFƒAŒ`¬‘jŠQÜƒXƒgƒŒƒvƒgƒXƒtƒFƒŠƒ“A‚Ì’P—£E\‘¢‰ðÍ. “ú–{–òŠw‰ï‘æ144”N‰ïi‰¡•lj, ‰¡•l, 3ŒŽ, 2024.
4) Š|’JGº. “V‘R•š‘n–òƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[‚ðŠî”Õ‚Æ‚µ‚œ•ªŽq•W“IR‚ª‚ñÜŠJ”­Œ€‹†. ‚ª‚ñŽ¡—ÃCƒmƒx[ƒVƒ‡ƒ“‚ÉŒü‚¯‚Ä. ‹ž“s‘åŠw‚“™Œ€‹†‰@E•šŽ¿E×–E“‡‹’“_@—ÊŽqƒiƒmˆã—ÃŒ€‹†ƒZƒ“ƒ^[, ‹ž“s, 3ŒŽ, 2024.iµ‘ҍu‰‰j
3) Kakeya, H. Natural products-inspired chemical biology-Development of a novel asparagine synthetase inhibitor for cancer chemotherapy-, Asian Chemical Biology Initiative (ACBI) 2024 Istanbul Meeting, Istanbul, Turkey, Mar. 2024. iinvitedj@@
2) Matsuoka, T., Hattori, A., Oishi, S., Araki, M., Ma, B., Fujii, T., Arichi, N., Okuno, Y., Kakeya, H., Yamasaki, S., Ohno, H., Inuki, S. Establishment of an MR1-presentation reporter screening system to identify MAIT cell modulation. CD1-MR1 2024, Tasmania, Australia, Feb., 2024.
1) ”öè œ, ‰ºŠÔŽuŽm, ‘q‰iŒ’Žj, Š|’JGº, œA£P‹v, . ‚ŠŽ“xŒõŠw•ªŠ„ƒ‰ƒxƒ‹‰»ÜL-FDVDA‚ð—p‚¢‚œ¶‘ÌŽŽ—¿EH•i‚©‚ç‚̃Aƒ~ƒm—Ž_‚̍‚ŠŽ“x•ªÍ–@‚ÌŠm—§. ‘æ15‰ñJapan@Bioanalysis Forum (JBF) ƒVƒ“ƒ|ƒWƒEƒ€, ‹ž“s, 3ŒŽ, 2024.

2023

37) Kakeya, H. Natural products-inspired chemical biology-Development of highly sensitive labeling reagents-, Asian Chemical Biology Initiative (ACBI) 2023 Kuala Lumpur Meeting, Kuala Lumpur, Malaysia, Dec. 2023. iinvitedj
36) Š|’JGº, “V‘R•š‘n–òƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[FV‹KƒAƒ~ƒmŽ_Eƒyƒvƒ`ƒh•ªÍ–@‚ÌŠJ”­‚Ɖž—p. ‘æ13‰ñVƒAƒ~ƒmŽ_•ªÍŒ€‹†‰ï, “Œ‹ž, 12ŒŽ, 2023. iµ‘ҍu‰‰j@@
35) œA£P‹v, ”öè œ, ’†o—F”ü, ‰ºŠÔŽuŽm, ’r“c–Ÿ‰Ä—¢, ‘q‰iŒ’Žj, Š|’JGº. ‚ŠŽ“xŒõŠw•ªŠ„ƒ‰ƒxƒ‹‰»ÜD-FDLDA‚ð—p‚¢‚œ”­yH•i’†‚ÌDL-ƒAƒ~ƒmŽ_•ªÍ. ‘æ13‰ñVƒAƒ~ƒmŽ_•ªÍŒ€‹†‰ï, “Œ‹ž, 12ŒŽ, 2023.
34) ”öè œ, ‰ºŠÔŽuŽm, ‘q‰iŒ’Žj, Š|’JGº, œA£P‹v. ‚ŠŽ“xŒõŠw•ªŠ„ƒ‰ƒxƒ‹‰»ÜL-FDVDA‚ð—p‚¢‚œƒAƒ~ƒm—Ž_‚̍\‘¢ˆÙ«‘Ì‚ÆŒõŠwˆÙ«‘̂̈êÄ•ªÍ. ˆêÄ•ªÍ–@‚ÌŠm—§. ‘æ13‰ñVƒAƒ~ƒmŽ_•ªÍŒ€‹†‰ï, “Œ‹ž, 12ŒŽ, 2023.
33) Sun, Y., Hashizume, D., Kakeya, H. Synthetic study of 2-(1H-imidazole-4-yl)-1,3,4-oxadiazole scaffolds for pharmaceuticals. The 40th Medicinal Chemistry Symposium. Nagoya, Nov., 2023.
32) Koyama, A., Kuranaga, T., Morimoto, R., Matsumoto, T., Kakeya, H. Acyl sulfonamide-mediated amidation and its application to the synthesis of middle molecular natural peptidic molecules. The 60th Japanese Peptide Symposium, Shiga, Nov. 2023.
31) Kuranaga, T., Morimoto, R., Pan, C., Ogawa, H., Kakeya, H. Design, synthesis, and application of highly sensitive labeling reagent for amino acids. The 60th Japanese Peptide Symposium, Shiga, Nov. 2023.
30) Ozaki, M., Shimotsuma, M., Kuranaga, T., Kakeya, H., Hirose, T. Identification of DL-amino acids containing threonine and isoleucine stereoisomers in peptides using an original chiral resolution labeling reagent. The 60th Japanese Peptide Symposium, Shiga, Nov. 2023.
29) Š|’JGº. “V‘R•šƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[‚ðŠî”Õ‚Æ‚µ‚œ‘n”­ˆã–ò‰ÈŠwŒ€‹†. ‘æ9‰ñ–òŠw‚Ì–¢—ˆ‚ðl‚Š‚é‹ž“sƒVƒ“ƒ|ƒWƒEƒ€F‘n”­ˆã–ò‰ÈŠwêUŠJŠw‹L”OƒVƒ“ƒ|ƒWƒEƒ€, ‹ž“s, 11ŒŽ, 2023. iµ‘ҍu‰‰j
28) Pan, Y., Suzuki, T., Sakai, K., Hirano, Y., Ikeda, H., Hattori, A., Dohmae, N., Nishio, K., Kakeya, H. Identification of an asparagine synthetase inhibitor bisabosqual A as an anticancer seed. The 3rd network salon, Medical Innovation Program, Kyoto University, Kyoto, Sep. 2023.
27) Kodama, K., Ikeda, H., Shibasaki, M., Kawami, M., Imoto, M., Kakeya, H. Screening and identification of anticancer lead compounds through a novel strategy targeting cancer stem cells. The 3rd network salon, Medical Innovation Program, Kyoto University, Kyoto, Sep. 2023.
26) Kakeya, H., Ozaki, M., Shimotsuma, M., Kuranaga, T., Hirose, T. Development of a new chiral resolution labeling reagent and aplication to separation of amyloid b fragment peptides with racemized and isomerized aspartic acid residues. The 3rd network salon, Medical Innovation Program, Kyoto University, Kyoto, Sep. 2023.
25) Koyama A., Kuranaga, T., Morimoto, R., Matsumoto, T., Kakeya, H. A novel peptide C-terminal modification and its application to the synthesis of middle molecular cyclic peptides. The 3rd network salon, Medical Innovation Program, Kyoto University, Kyoto, Sep. 2023.
24) Sun, Y., Hashizume, D., Kakeya, H. Studies on 2-(1H-imidazol-4-yl)-1,3,4-oxadiazole scaffolds for pharmacological molecules. The 3rd network salon, Medical Innovation Program, Kyoto University, Kyoto, Sep. 2023.
23) œA£P‹v, ”öè œ, ’†o—F”ü, ‰ºŠÔŽuŽm, ‘q‰iŒ’Žj, Š|’JGº. ‚ŠŽ“xŒõŠw•ªŠ„ƒ‰ƒxƒ‹‰»ÜD-FDLDA‚ð—p‚¢‚œH•i’†‚ÌDL-ƒAƒ~ƒmŽ_•ªÍ. “ú–{ƒAƒ~ƒmŽ_Šw‰ï‘æ17‰ñŠwp‘å‰ï (JSAA2023), •Ÿ‰ª, 9ŒŽ, 2023.
22) ”öè œ, ‰ºŠÔŽuŽm, ‘q‰iŒ’Žj, Š|’JGº, œA£P‹v, . ‚ŠŽ“xŒõŠw•ªŠ„ƒ‰ƒxƒ‹‰»ÜL-FDVDA‚ð—p‚¢‚œ‘SƒAƒ~ƒm—Ž_ˆêÄ•ªÍ–@‚ÌŠm—§. “ú–{ƒAƒ~ƒmŽ_Šw‰ï‘æ17‰ñŠwp‘å‰ï (JSAA2023), •Ÿ‰ª, 9ŒŽ, 2023.
21) ’†o—F”ü, ”öè œ, ‰ºŠÔŽuŽm, ‘q‰iŒ’Žj, Š|’JGº, œA£P‹v. ŒõŠw•ªŠ„ƒ‰ƒxƒ‹‰»ÜL-FDVDA‚ð—p‚¢‚œƒyƒvƒ`ƒh’†‚ÌThr‚ÆIle‚Ì—§‘ِ̈«‘Ì‚Ì“¯’è. “ú–{ƒAƒ~ƒmŽ_Šw‰ï‘æ17‰ñŠwp‘å‰ï (JSAA2023), •Ÿ‰ª, 9ŒŽ, 2023.
20) ¬ŽR ˆ€, ‘q‰iŒ’Žj, X–{—Á‘Ÿ, ŒŒ³‘ñŠC, Š|’JGº. ƒGƒsƒƒŠ‰»‚ð—}§‚·‚éƒyƒvƒ`ƒhC––’[Cü–@‚Æ’†•ªŽqŠÂóƒyƒvƒ`ƒh‡¬‚ւ̉ž—p. ‘æ65‰ñ“V‘R—L‹@‰»‡•š“¢˜_‰ï, “Œ‹ž, 9ŒŽ, 2023.@@@@@.@@
19) Ž™‹Ê ŠJ, ’r“c‘ñŒd, ŽÄèŽçO, ìŒ©”ü—¢, ˆä–{³Æ, Š|’JGº. ‚ª‚ñŠ²×–E‚ð•W“I‚Æ‚µ‚œR‚ª‚ñÜƒV[ƒY‚ÌŠJ”­Œ€‹†. ‘æ33‰ñV–ò‘n»’k˜b‰ï. ‹ž“s, 9ŒŽ, 2023. [Œ€‹†§—ãÜ]@@
18) ¬ŽR ˆ€, ‘q‰iŒ’Žj, X–{—Á‘Ÿ, ŒŒ³‘ñŠC, Š|’JGº. ’†•ªŽqƒyƒvƒ`ƒh‘n–ò‚ðŽuŒü‚µ‚œV‹Kƒyƒvƒ`ƒh‡¬–@‚ÌŠJ”­. ‘æ33‰ñV–ò‘n»’k˜b‰ï, ‹ž“s, 9ŒŽ, 2023.@@@@@.@@
17) Œ‰ª‘ñ˜N, •ž•” –Ÿ, ‘åÎ^–ç, r–Ø–]Žk, —L’n–@l, Š|’JGº, ŽRè », ‘å–ì_Í, ˆäŠÑW•ã. ×–E•\–Ê‚ÌMR1‘¶Ý—Ê‚ÉŠî‚­ƒŠƒKƒ“ƒhƒXƒNƒŠ[ƒjƒ“ƒO–@‚ÌŠJ”­‚ÆMAIT×–E§Œä•ªŽq‚Ì“¯’è. ‘æ65‰ñ“V‘R—L‹@‰»‡•š“¢˜_‰ï, “Œ‹ž, 9ŒŽ, 2023.@@@@@.@@
16) Yanaka, K., Hirano, Y., Qiun, X.Y., Suzuki, H., Kakeya, H., Matsuura, T., Furutani, Y. A small chemical compound iCDM-34 identified by an in silico screening suppresses HBV DNA through activation of aryl hydrocarbon receptor, 2023 Interbational HBV Meeting, Kobe, Sep. 2023.@@@.@@
15) Š|’JGº. ƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[‚ð‹@Ž²‚Æ‚µ‚œ•ªŽqƒvƒƒtƒ@ƒCƒŠƒ“ƒO, 2023”N“xŽáŽèŽx‰‡‹ZpuK‰ï, •¶•”‰ÈŠwÈŠwp•ÏŠvŒ€‹† ŠwpŒ€‹†Žx‰‡Šî”ÕŒ`¬ æ’[ƒ‚ƒfƒ‹“®•šŽx‰‡ƒvƒ‰ƒbƒgƒtƒH[ƒ€iADAMsj, –ŒŒÃ‰®, 9ŒŽ, 2023. iµ‘ҍu‰‰j
14) Š|’JGº. “V‘R•š‘n–òƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[‚̍őOüFŽYŠw˜AŒg‚É‚æ‚éˆã–ò•i‚ÌŽÀ—p‰»‚ÉŒü‚¯‚Ä, Œ’“sƒCƒmƒx[ƒVƒ‡ƒ“ƒp[ƒNŒð—¬ƒZƒ~ƒi[iŽåÃF‡Š‹ž“sƒŠƒT[ƒ`ƒp[ƒNj, ‘åã, 7ŒŽ, 2023. iµ‘ҍu‰‰j
13) Š|’JGº. ƒVƒ“ƒ|ƒWƒEƒ€1Eu•W“I‚ðŽË”²‚¯Ii’ᕪŽqE’†•ªŽqER‘́jv\“V‘R•š‘n–òFƒAƒXƒpƒ‰ƒMƒ“‡¬y‘f‚ðŽË”²‚­. ‘æ27‰ñ“ú–{‚ª‚ñ•ªŽq•W“IŽ¡—Êw‰ïŠwpW‰ï, ²‰ê, 6ŒŽ, 2023. iµ‘ҍu‰‰j
12) Pan, Y., Suzuki, T., Sakai, K., Hirano, Y., Ikeda, H., Hattori, A., Dohmae, N., Nishio, K., Kakeya, H. Identification of bisabosqual A as an asparagine synthetase (ASNS) inhibitor towards the development of molecular-targeted anticancer drug. The 17th Annual Meeting of Japanese Society for Chemical Biology, Osaka, May, 2023.
11) Kakeya, H. Development of an innovative anticancer drug TBP1901, an injectable prodrug of curcumin. 2023 NSFC*1-JSPS-CAS*2 Forum: Translational Medicine and Innovative Drug Research. Tianjin, China, Jun. 2023. (*1 Natural Science Foundation of China, *2 Chinese Academy of Science) [keynote lecture]
10) Œ‰ª‘ñ˜N, •ž•” –Ÿ, ‘åÎ^–ç, —L’n–@l, Š|’JGº, ŽRè », ‘å–ì_Í, ˆäŠÑW•ã. MR1‚̍זE•\–Ê—Ê‚ðŽw•W‚Æ‚·‚郊ƒKƒ“ƒhƒXƒNƒŠ[ƒjƒ“ƒO–@‚ÌŠJ”­‚ÆMAIT×–Eƒ‚ƒWƒ…ƒŒ[ƒ^[‚Ì“¯’è. “ú–{ƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[Šw‰ï@‘æ17‰ñ”N‰ï, ‘åã, 5ŒŽ, 2023.@@
9) Pan, Y., Suzuki, T., Sakai, K., Hirano, Y., Ikeda, H., Hattori, A., Dohmae, N., Nishio, K., Kakeya, H. Screening and identification of an asparagine synthetase (ASNS) inhibitor as a molecular-targeted anticancer drug. The 143rd Annual Meeting of Pharmaceutical Society of Japan. Hokkaido, Mar. 2023.@@@@@
8) ”öè œ, ‰ºŠÔŽuŽm, ‘q‰iŒ’Žj, Š|’JGº, œA£P‹v. DL-ƒAƒ~ƒmŽ_ƒ‰ƒxƒ‹‰»ƒLƒbƒg‚ð—p‚¢‚œƒAƒ~ƒƒCƒhƒÀ’†‚ÌAspŽcŠî‚̃‰ƒZƒ~‰»EˆÙ«‰»‚ÌŒŸo–@‚ÌŠJ”­\ŽŸŠ³‚ÉŠÖ—^‚·‚é‹ÃWƒ^ƒ“ƒpƒNŽ¿Eƒyƒvƒ`ƒh‚Ì‘Šúf’fEŽŸŠ³ƒƒJƒjƒYƒ€‚̉𖟂Ɍü‚¯‚ā\. ‘æ14‰ñJapan@Bioanalysis Forum (JBF) ƒVƒ“ƒ|ƒWƒEƒ€, “Œ‹ž, 3ŒŽ, 2023.
7) Ikeda, H., Shibasaki, M., Kodama, K., Kawami, M., Imoto, M., Kakeya, H. Screening for anticancer lead compounds through a new strategy for targeting cancer stem cells. Future Drug Discovery Empowered by Chemical Biology, Nara, Feb. 2023.
6) Sun, Y., Hashizume, D., Kakeya, H. Synthetic study on 2-(1H-imidazol-4-yl)-1,3,4-oxadiazole scaffolds for drug discovery. Future Drug Discovery Empowered by Chemical Biology, Nara, Feb. 2023.
5) Kuranaga, T., Tamura, M., Ikeda, H., Terada, S., Nakagawa, Y., Kakeya, H. Reactivity-guided identification and total synthesis of an unstable anticancer macrolide presaccharothriolide Z. Future Drug Discovery Empowered by Chemical Biology, Nara, Feb. 2023.
4) Kakeya, H., Abe, T., Horisawam Y., Kikuchi, O., Ozawa-Umeta, H., Kishimoto, A., Imaizumi, A., Hashimoto, T., Shirakawa, K., Takaori-Kondo, A., Yusa, K., Asakura, T., Kanai, M. Pharmacologic characterization of TBP1901, an innovative prodrug form of curcumin, and CRISPR-Cas9 screen for therapeutic targets of curcumin. Future Drug Discovery Empowered by Chemical Biology, Nara, Feb. 2023.
3) Koyama, A., Kuranaga, T., Morimoto, R., Kakeya, H. Acyl sulfamide-mediated amidation for biomimetic peptide synthesis. Future Drug Discovery Empowered by Chemical Biology, Nara, Feb. 2023.
2) Pan, Y., Suzuki, T., Sakai, K., Hirano, Y., Ikeda, H., Hattori, A., Dohmae, N., Nishio, K., Kakeya, H. Chemical biology research on an asparagine synthetase (ASNS) inhibitor as a molecular-targeted anticancer drug. Future Drug Discovery Empowered by Chemical Biology, Nara, Feb. 2023.
1) ˆÀ“c õ, ’|àV³–Ÿ, ‘q‰iŒ’Žj, Š|’JGº. V‹K—U“±‘̉»ŽŽ–ò‚ð—p‚¢‚œD,L-ƒAƒ~ƒmŽ_‚̍‚ŠŽ“x•ªÍ–@ŠJ”­. ‘æ28‰ñLC&MSƒeƒNƒmƒvƒ‰ƒU, ƒIƒ“ƒ‰ƒCƒ“ŠJÃ, 1ŒŽ, 2023. [ƒxƒXƒgƒvƒŒƒ[ƒ“ƒe[ƒVƒ‡ƒ“ÜiƒxƒXƒgƒe[ƒ}Üj]

2022

15) ”öè œ, ‰ºŠÔŽuŽm, ‘q‰iŒ’Žj, Š|’JGº, œA£P‹v. ŒõŠw•ªŠ„ƒ‰ƒxƒ‹‰»ÜD-FDLDA‚ð—p‚¢‚œƒAƒ~ƒƒCƒhƒÀ’†‚̃AƒXƒpƒ‰ƒMƒ“Ž_ŽcŠî‚̃‰ƒZƒ~‰»EˆÙ«‰»‚Ì“¯’è. VƒAƒ~ƒmŽ_•ªÍŒ€‹†‰ï‘æ12‰ñŠwpu‰‰‰ï, “Œ‹ž, 12ŒŽ, 2022. [—DG”­•\Ü]
14) ˆÀ“c õ, ’|àV³–Ÿ, ‘q‰iŒ’Žj, Š|’JGº. V‹K—U“±‘̉»ŽŽ–ò‚ð—p‚¢‚œ¶‘ÌŽŽ—¿’†‹y‚эזE”|—{ãŽ’†D,L-ƒAƒ~ƒmŽ_‚̍‚ŠŽ“x•ªÍ. VƒAƒ~ƒmŽ_•ªÍŒ€‹†‰ï‘æ12‰ñŠwpu‰‰‰ï, “Œ‹ž, 12ŒŽ, 2022.
13) Yasuda, Y., Takezawa, M., Kuranaga, T., Kakeya, H. Highly sensitiveanalysis of D-and L-amino acids in biological samples using new derivatization reagents. The 37th Annual Meeting of the Japanese Society for the study of Xenobiotics, Kanagawa, Nov. 2022.@
12) Œ‰ª‘ñ˜N, •ž•” –Ÿ, ‘åÎ^–ç, —L’n–@l, Š|’JGº, ŽRè », ‘å–ì_Í, ˆäŠÑW•ã. ƒXƒvƒŠƒbƒgƒ‹ƒVƒtƒFƒ‰[ƒ[‚ð—˜—p‚µ‚œƒXƒNƒŠ[ƒjƒ“ƒO–@‚É‚æ‚éV‹KMR1ƒŠƒKƒ“ƒh‚Ì“¯’è‚Æ‚»‚̍\‘¢Šˆ«‘ŠŠÖŒ€‹†. ‘æ39‰ñƒƒfƒBƒVƒiƒ‹ƒPƒ~ƒXƒgƒŠ[ƒVƒ“ƒ|ƒWƒEƒ€, 11ŒŽ, 2022, ƒIƒ“ƒ‰ƒCƒ“ŠJÃ.@@@@@
11) Ozaki, M., Shimotsuma, M., Kuranaga, T., Kakeya, H., Hirose, T. Identification of DL-and DL-iso-form of aspartic acid residues in amyloid b peptide using a chiral resolution labeling reagent. The 59th Japanese Peptide Symposium, Miyagi, Oct. 2022.
10) Ikeda, H., Imoto, M., Kakeya, H. Identification of the polyether ionophore lenoremycin through a new screening strategy targeting cancer stem cells. The 81st Annual Meeting of the Japanese Cancer Association. Kanagawa, Sep. 2022. [selected as a late-breaking poster]@@@@@
9) Kura, Y., Develasco, M.A., Sakai, K., Fujita K., Bannno, E., Fujita, Y., Hashimoto, M., Nishimoto, M., Nozawa, M., Yoshimura, K., Kakeya, H., Umemura, H., Nishio, K. Chemopreventive potential of curcumin monoglucuronide in mouse Pten-null prostate cancer. The 81st Annual Meeting of the Japanese Cancer Association. Yokohama, Sep. 2022.@@@@@
8) ‘q‰iŒ’Žj, “c‘º”ü”¿, ’r“c‘ñŒd, Ž›“c‰ ”V, ’†ì—Y‰î, Š|’JGº. ‰»Šw‡¬‚ð‹ìŽg‚µ‚œŠó­R‚ª‚ñŠˆ«“V‘R•šƒvƒŒƒTƒbƒJƒƒXƒŠƒIƒŠƒhZ‚Ì“¯’è. ‘æ64‰ñ“V‘R—L‹@‰»‡•š“¢˜_‰ï, Ã‰ª, 9ŒŽ, 2022.@@@@@
7) Š|’JGº, ‘q‰iŒ’Žj, ’r“c‘ñŒd, •ž•” –Ÿ, Œ‘ºTˆê, ˆä–{³Æ. ”÷¶•šŠÔ‰»ŠwƒRƒ~ƒ…ƒjƒP[ƒVƒ‡ƒ“‚Ì—‰ð‚Æ—L—p¶•šŠˆ«ƒŠƒKƒ“ƒh‚ÌŠJ”­. VŠwp—̈挀‹†u‰»ŠwƒRƒ~ƒ…ƒjƒP[ƒVƒ‡ƒ“‚̃tƒƒ“ƒeƒBƒAvŽæ‚è‚܂Ƃ߃Vƒ“ƒ|ƒWƒEƒ€, ‹ž“s, 7ŒŽ, 2022.
6) Š|’JGº. “V‘R•š‘n–òƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[‚̍őOü. –k—¢‘åŠw‘æ100‰ñKMCFƒZƒ~ƒi[iKitasato Microbial Chemistry Frontierj, “Œ‹ž, 6ŒŽ, 2022. iµ‘ҍu‰‰j
5) Îì•¶—m, “à“cç°, ‘同—˜“Þ, ¡–ìãÄ, —é–ØŒ’—T, ‚“‡Ž‹P, “°‘O’Œ, Š|’JGº, “c糌³ŽO. ×–E“à‚Å‚Ì”ñƒŠƒ{ƒ\[ƒ€ƒyƒvƒ`ƒh‡¬y‘f‚Ì‘I‘ð“Iƒ‰ƒxƒ‹‰»‚š‚æ‚Ñ•ª‰ð‹@\‚Ì”­Œ©. “ú–{ƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[Šw‰ï@‘æ16‰ñ”N‰ï, •xŽR, 5ŒŽ, 2022.@@
4) ²X–Ø•‘á, Œ‘ºTˆê, ŒŽRW‹v, ”ª‘ã“c—zŽq, Š|’JGº, ‹g“c–«. FKBP12‚É‚æ‚éƒZƒŠƒ“EƒXƒŒƒIƒjƒ“‘ãŽÓ§Œä‚̉»Šwˆâ“`Šw“I‰ðÍ. “ú–{”_Œ|‰»Šw‰ï2022”N“x‘å‰ï, ‹ž“siƒIƒ“ƒ‰ƒCƒ“j, 3ŒŽ, 2022.
3) Îì•¶—m, ¡–ìãÄ, “à“cç°, —é–ØŒ’—T, ‚“‡Ž‹P, “°‘O’Œ, Š|’JGº, “c糌³ŽO. ×–E“à‚Å‚Ì”ñƒŠƒ{ƒ\[ƒ€ƒyƒvƒ`ƒh‡¬y‘f‚Ì‘I‘ð“IƒPƒ~ƒJƒ‹ƒ‰ƒxƒŠƒ“ƒO‚š‚æ‚Ñ•ª‰ð‰ß’ö‚Ì”­Œ©. “ú–{–òŠw‰ï‘æ142”N‰ï. –ŒŒÃ‰®iƒIƒ“ƒ‰ƒCƒ“j, 3ŒŽ, 2022.@@
2) Watari, S., Kaneko, K., Iwata, S., Nagao, N., Onaka, H., Shinzato, N., Kakeya, H. Syetematic screening of new microbial metabolites by combined-culture of actinomycetes. Japan-the Netherlands Microbiology Symposium 2022, Mar. 2022 (Kochi/on-line).@@@@@
1) Kakeya, H. Chemical communication research on microbes toward the development of novel antibiotics. Japan-the Netherlands Microbiology Symposium 2022, Mar. 2022 (Kochi/on-line). (Invited lecture)@@@@@

2021

18) Kakeya, H. Chemical communication research toward the development of novel antibiotics. (#182 Antibiotics Discovery), PACIFICHEM2021, Hawaii, USA, Dec. 2021. (Invited lecture)@@@@
17) Kakeya, H. Chemical communication research toward the development of new anticancer drugs. (#79 Chemical Communications through Natural and Synthetic Bioactive Compounds), PACIFICHEM2021, Hawaii, USA, Dec. 2021.@@
16) Omura, S., Khadka, S., Sato, F., Nakamura, Y., Nishio, K., Kakeya, H., Tsunoda, I. Curcumin mooglucuronide (CMG) treatment alters the gut microbiota, regulating an autoimmune model for multiple sclerosis. (#79 Chemical Communications through Natural and Synthetic Bioactive Compounds), PACIFICHEM2021, Hawaii, USA, Dec. 2021.@@
15) Ikeda, H., Muroi, M., Kondoh, Y., Ishikawa, S., Kakeya, H., Osada, H., Imoto, M. Miclxin, a novel MIC60 inhibitor, induces apoptosis via mitochondrial stress in beta-catenin mutant tumor cells. (#79 Chemical Communications through Natural and Synthetic Bioactive Compounds), PACIFICHEM2021, Hawaii, USA, Dec. 2021.@@
14) Matsumoto, T., Jiang, Y., Kuranaga, T., Lu, S., Wang, W., Onaka, H. Kakeya, H. Discovery of longicatenamides A-D produced by combined-culture of Streptomyces sp. KUSC_F05 and Tsukamurella pulmonis TP-B0596. (#79 Chemical Communications through Natural and Synthetic Bioactive Compounds), PACIFICHEM2021, Hawaii, USA, Dec. 2021.@@
13) Kuranaga, T., Minote, M., Morimoto, R., Pan, C., Ogawa, H., Kakeya, H. Highly sensitive amino acid labeling reagents inspired by a scarce natural product yaku'amide B. (#79 Chemical Communications through Natural and Synthetic Bioactive Compounds), PACIFICHEM2021, Hawaii, USA, Dec. 2021.@@
12) Minote, M., Kuranaga, T., Morimoto, R., Pan, C., Ogawa, H., Kakeya, H. Design, synthesis , and application of highly sensitive labeling reagents inspired by a scarce natural product. (#79 Chemical Communications through Natural and Synthetic Bioactive Compounds), PACIFICHEM2021, Hawaii, USA, Dec. 2021.@@
11) ŒŒ³‘ñŠC, Yulu Jiang, ‘q‰iŒ’Žj Shun Lu, Weicheng Wang, ”ö’‡GN, Š|’JGº. •úü‹Û—R—ˆƒƒ“ƒMƒJƒeƒiƒ~ƒhA-D‚ÉŠÖ‚·‚錀‹†FˆÙ‘®”÷¶•š‚Ì•¡‡”|—{‚É‚æ‚鐶ŽYA\‘¢Œˆ’èA¶•šŠˆ«A‹y‚Ñ‘S‡¬. ‘æ63‰ñ“V‘R—L‹@‰»‡•š“¢˜_‰ï, ‘åãiƒnƒCƒuƒŠƒbƒhj, 9ŒŽ, 2021.@@@@@
10) Kura, Y., Velasco, M.D., Sakai, K., Fujita, Y., Hashimoto, M., Kakeya, H., Uemura, H., Nishio, K. Curcumin monoglucuronide modulates the tumor microenvironment of Pten-null prostate tumors and exhits antitumor activity The 80th Annunal Meeting of the Japan Cancer Asscociation. Sep. Yokohama, 2021.
9) Îì•¶—m, ¡–ì@ãÄ, “à“cç°, —é–ØŒ’—T, “°‘O@’Œ, Š|’JGº, “c糌³ŽO. ×–E“à‚Å‚Ì”ñƒŠƒ{ƒ\[ƒ€ƒyƒvƒ`ƒh‡¬y‘f‚Ì‘I‘ð“IƒPƒ~ƒJƒ‹ƒ‰ƒxƒŠƒ“ƒO. ‘æ15‰ñƒoƒCƒIŠÖ˜A‰»ŠwƒVƒ“ƒ|ƒWƒEƒ€, 9ŒŽ, 2021.@@
8) ²X–Ø•‘á, Œ‘ºTˆê, ŒŽRW‹v, ”ª‘ã“c—zŽq, Š|’JGº, ‹g“c@–«. •ª—ôy•ê‚É‚š‚¯‚éƒZƒŠƒ“‘ãŽÓ§Œä‹@\‚̉»Šwˆâ“`Šw“I‰ðÍ. y•êˆâ“`ŠwƒtƒH[ƒ‰ƒ€‘æ54‰ñŒ€‹†•ñ‰ï, –ŒŒÃ‰®, 9ŒŽ, 2021.@
7) Š|’JGº, ‘q‰iŒ’Žj, ’r“c‘ñŒd, Œ‘ºTˆê, ˆä–{³Æ. ”÷¶•šŠÔ‰»ŠwƒRƒ~ƒ…ƒjƒP[ƒVƒ‡ƒ“‚Ì—‰ðE§Œä‚Æ—L—p¶•šŠˆ«ƒŠƒKƒ“ƒh‚ÌŠJ”­. VŠwp—̈挀‹†u‰»ŠwƒRƒ~ƒ…ƒjƒP[ƒVƒ‡ƒ“‚̃tƒƒ“ƒeƒBƒAvE‘æ8‰ñŒöŠJƒVƒ“ƒ|ƒWƒEƒ€. ‹ž“siƒIƒ“ƒ‰ƒCƒ“j 7ŒŽ, 2021.
6) Œ‰ª‘ñ˜N, –{‰€çq, •ž•”@–Ÿ, Š|’JGº, ŽRè@», ‘åÎ^–ç, ‘å–ì_Í, ˆäŠÑW•ã. MAIT×–E‚ÌŠˆ«‰»‚ð’S‚€MR1ƒŠƒKƒ“ƒh‚Ì’TõŒ€‹†. VŠwp—̈挀‹†u‰»ŠwƒRƒ~ƒ…ƒjƒP[ƒVƒ‡ƒ“‚̃tƒƒ“ƒeƒBƒAvE‘æ8‰ñŒöŠJƒVƒ“ƒ|ƒWƒEƒ€. ‹ž“siƒIƒ“ƒ‰ƒCƒ“j ,7ŒŽ, 2021.@@
5) ’r“c‘ñŒd, ìŒ©”ü—¢, ˆä–{³Æ, Š|’JGº. ‚ª‚ñŠ²×–E‚ð•W“I‚Æ‚µ‚œR‚ª‚ñÜƒV[ƒY‚Ì’TõŒ€‹†. “ú–{ƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[Šw‰ï@‘æ15‰ñ”N‰ï. •Ÿ‰ªiƒIƒ“ƒ‰ƒCƒ“j, 6ŒŽ, 2021.@@
4) X–{—Á‘Ÿ, ŒŒ³‘ñŠC, –¥Žè–œ—R—¢, –ö‘ò«s, ŽR“c—³‘Ÿ˜Y, ‘q‰iŒ’Žj, Š|’JGº. LC-MS‚ð—p‚¢‚œ’†«ðŒ‰º‚̍DŠŽ“xƒAƒ~ƒmŽ_•ªÍ. ‘n–ò§˜b‰ï 2020 in ‹ž“s. ‹ž“siƒIƒ“ƒ‰ƒCƒ“j, 6ŒŽ, 2021.
3) Œ‰ª‘ñ˜N, –{‰€çq, •ž•”@–Ÿ, Š|’JGº, ŽRè@», ‘åÎ^–ç, ‘å–ì_Í, ˆäŠÑW•ã. MAIT×–EŠˆ«‰»Ü5-OP-RU‚̍\‘¢Šˆ«‘ŠŠÖŒ€‹†. “ú–{ƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[Šw‰ï@‘æ15‰ï”N‰ï–òŠw‰ï. •Ÿ‰ªiƒIƒ“ƒ‰ƒCƒ“j, 6ŒŽ, 2021.@@
2) ’r“c‘ñŒd, ìŒ©”ü—¢, ˆä–{³Æ, Š|’JGº. ‚ª‚ñŠ²×–E‚ð•W“I‚Æ‚µ‚œR‚ª‚ñÜƒV[ƒY’TõŒn‚̍\’z. “ú–{–òŠw‰ï‘æ141”N‰ï. ‹ž“s, 3ŒŽ, 2021.@@
1) Žðˆä–ƒ—˜“Þ, ‚‹ŽL–Ÿ, ŒÃ’J@—T, —é–ØŒ’—T, “°‘O@’Œ, ¬—ѐŽ, •ž•”@–Ÿ, ŒŽ“c@_, Š|’JGº. ƒsƒ‰ƒ][ƒ‹œŠi‚ð—L‚·‚éV‹K’áŽ_‘f—U“±ˆöŽqHIF-1‘jŠQÜ‚ÌŠJ”­Œ€‹†. “ú–{–òŠw‰ï‘æ141”N‰ï. L“‡, 3ŒŽ, 2021.@@

2020

16) Š|’JGº. Ž©‘R‚ÉŠw‚Ԑ¶—‰»ŠwŒ€‹†F•ªŽqƒvƒ[ƒuŠJ”­‚Æ‘n–ò. ‹ž“s‘åŠwŠwÛ—Z‡‹³ˆç„iƒZƒ“ƒ^[E¶—‰»ŠwŒ€‹†ƒ†ƒjƒbƒg‘æ10‰ñŒöŠJƒVƒ“ƒ|ƒWƒEƒ€. ‹ž“s, 12ŒŽ, 2020. @@
15) Š|’JGº, ‘q‰iŒ’Žj. ‘n–òEˆç–ò‚Ö‚Ì’§íFŽ©‘R‚ÉŠw‚ÔƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[Œ€‹†. ‹ž“s‘åŠwu‚Š‚é‚«‚á‚·vƒIƒ“ƒ‰ƒCƒ“2020. ‹ž“s, 10ŒŽ, 2020. @@
14) Pan, C., Kuranaga, T., Liu, C., Lu, S., Shinzato, N., Kakeya, H. Discovery of sulfur-containing cyclic lipopeptides thioamycolamides A-E, produced by the rare ctinomycete Amycolatopsis sp., The 62nd Symposium on the Chemistry of Natural Products, Nagoya, Sep. 2020.@@
13) –¥Žè–œ—R—¢, ¬ì‚Í‚é‚©, X–{—Á‘Ÿ, àN ³Œª, ‘q‰iŒ’Žj, Š|’JGº. Šó­“V‘R•š‚̍\‘¢‚ðƒ‚ƒ`[ƒt‚Æ‚µ‚œ‚ŠŽ“xƒ‰ƒxƒ‹‰»Ü‚ÌŠJ”­. “ú–{–òŠw‰ï‘æ140”N‰ï. ‹ž“s, 3ŒŽ, 2020.iu‰‰ƒnƒCƒ‰ƒCƒgj
@@
12) “c‘º”ü”¿, ’†ì—Y‰î, ‘q‰iŒ’Žj, Š|’JGº. “V‘Rƒvƒƒhƒ‰ƒbƒOŒ^R‚ª‚ñÜƒŠ[ƒh‰»‡•šƒTƒbƒJƒƒXƒŠƒIƒŠƒhB‚Ì‘S‡¬Œ€‹†. “ú–{–òŠw‰ï‘æ140”N‰ï. ‹ž“s, 3ŒŽ, 2020.@@@
11) ’|’†@Œd, Œ‘ºTˆê, ‹àŽqŒ«‰î, Shan Lu, Š|’JGº. “V‘R—L‹@‰»‡•šsaccharothriolide B‚É’…‘z‚ð“Ÿ‚œƒvƒƒhƒ‰ƒbƒO‹Zp‚ÌŠJ”­Œ€‹†. “ú–{–òŠw‰ï‘æ140”N‰ï. ‹ž“s, 3ŒŽ, 2020.@@@
10) X–{—Á‘Ÿ, ‘q‰iŒ’Žj, ˜e–{•qK, Š|’JGº. ŽÀ—p“Iinverseƒyƒvƒ`ƒh‡¬–@‚ÌŠJ”­. “ú–{–òŠw‰ï‘æ140”N‰ï. ‹ž“s, 3ŒŽ, 2020.@@
9) ‰““¡Œ’‘Ÿ, •ž•” –Ÿ, —› á•X, ¬ì—SŽ÷, àN ³Œª, Š|’JGº. ’Eƒ†ƒrƒLƒ`ƒ“‰»y‘fUSP47‚ÆCateninD1‚Ì‚ª‚ñˆ««‰»‚É‚š‚¯‚é‹@”\˜AŠÖ. “ú–{–òŠw‰ï‘æ140”N‰ï. ‹ž“s, 3ŒŽ, 2020.@@
8) Š|’JGº. ƒAƒJƒfƒ~ƒA”­‘n–ò‚ð–ÚŽw‚µ‚œ‘n–òƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[Œ€‹†. TSMTP (Translational Science and Medicine Training Program) Symposium in Sapporo, ŽD–y, 2ŒŽ, 2020. iµ‘ҍu‰‰j@@@@
7) Kaneko, K., Nagao, N., Onaka, H., Shinzato, N., Kakeya, H. Detection of combined-culture specific constituents by the Molecular Networking and multivariate analyses. The 4th Kyoto Biomolecular Mass Spectrometry Society (KBMSS), Kyoto, Feb. 2020.
6) Š|’JGº, ŠÝ–{[O, ”~“c-¬àV“µ, ‚‹ŽL–Ÿ, ‹g“c¹ˆ», ‘q‰iŒ’Žj, ¡òŒú, ‹Ž–{³, ‹àˆä‰ëŽj. …—n«ƒvƒƒhƒ‰ƒbƒOŒ^•ªŽq•W“IR‚ª‚ñÜCMG‚ÌŠJ”­Œ€‹†. ‹ž“s‘åŠwƒƒfƒBƒJƒ‹ƒCƒmƒx[ƒVƒ‡ƒ“iMiPj‘ì‰z‘åŠw‰@ƒvƒƒOƒ‰ƒ€Eˆã–òŒnŒ€‹†Œð—¬ƒTƒƒ“, ‹ž“s, 1ŒŽ, 2020.@@@
5) ‘q‰iŒ’Žj, ¬ì‚Í‚é‚©, –¥Žè–œ—R—¢, X–{—Á‘Ÿ, àN³Œª, Š|’JGº. ‹H­ŠC—m“V‘R•š‚ð‹@”\ƒ‚ƒ`[ƒt‚É‚µ‚œ‚ŠŽ“xƒ‰ƒxƒ‹‰»Ü. ‹ž“s‘åŠwƒƒfƒBƒJƒ‹ƒCƒmƒx[ƒVƒ‡ƒ“iMiPj‘ì‰z‘åŠw‰@ƒvƒƒOƒ‰ƒ€Eˆã–òŒnŒ€‹†Œð—¬ƒTƒƒ“, ‹ž“s, 1ŒŽ, 2020.@@@@@@@
4) •ž•”–Ÿ, àN³Œª, •Ÿ‰ªŒ[‘Ÿ, “ˆ“cŽ, ‰““¡Œ’‘Ÿ, ¬ì—SŽ÷, Š|’JGº. ƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[‚ðŠî”Õ‚Æ‚µ‚œ’Eƒ†ƒrƒLƒ`ƒ“‰»y‘fUSP47‚̐¶—‹@”\‰ðÍ. ‹ž“s‘åŠwƒƒfƒBƒJƒ‹ƒCƒmƒx[ƒVƒ‡ƒ“iMiPj‘ì‰z‘åŠw‰@ƒvƒƒOƒ‰ƒ€Eˆã–òŒnŒ€‹†Œð—¬ƒTƒƒ“, ‹ž“s, 1ŒŽ, 2020.@@@@
3) ‘q‰iŒ’Žj, •ž•”–Ÿ, Š|’JGº. ‘n–òƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[Œ€‹†. ‹ž“s‘åŠwƒƒfƒBƒJƒ‹ƒCƒmƒx[ƒVƒ‡ƒ“iMiPj‘ì‰z‘åŠw‰@ƒvƒƒOƒ‰ƒ€Eˆã–òŒnŒ€‹†Œð—¬ƒTƒƒ“, ‹ž“s, 1ŒŽ, 2020.@@@@
2) Š|’JGº. —L—p¶•šŠˆ«ƒŠƒKƒ“ƒh‚ÌŠJ”­‚ðŽuŒü‚µ‚œ‰»ŠwƒRƒ~ƒ…ƒjƒP[ƒVƒ‡ƒ“Œ€‹†. —L‹@‡¬‚̃jƒ…[ƒgƒŒƒ“ƒh2020i—L‹@‡¬‰»Šw‹Š‰ïŠÖŒŽx•”ŽåÃj, ‘åã, 2ŒŽ, 2020. iµ‘ҍu‰‰j@@@@
1) Kakeya, H. Continuing Fascination with Discovery Science: Phenotypic Screening to Chemical Biology. Mona Symposium 2020: Natural Product Chemistry and Medicinal Chemistry. Kingston, Jamaica, Jan. 2020. (plenary lecture)

2019

32) Š|’JGº. ”÷¶•šŠÔ‰»ŠwƒRƒ~ƒ…ƒjƒP[ƒVƒ‡ƒ“‚Ì—‰ð‚Æ—L—p¶•šŠˆ«ƒŠƒKƒ“ƒh‚ÌŠJ”­. VŠwp—̈挀‹†u‰»ŠwƒRƒ~ƒ…ƒjƒP[ƒVƒ‡ƒ“‚̃tƒƒ“ƒeƒBƒAvE‘æ6‰ñŒöŠJƒVƒ“ƒ|ƒWƒEƒ€. ‰¡•l, 12ŒŽ, 2019. iµ‘ҍu‰‰j@@@
31) Kakeya, H. Chemical comunication research toward the development of useful chemical probes. The 4th A3 Roundtable Meeting on Asia Chemical Probe Research, Sendai, Nov. 2019. (Plenary lecture)@@@@
30) Kakeya, H. Natural products-prompted chemical biology: Phenotypic screening and a new platform for target identification. The 6th Tishler-Omura Sympoium, Tokyo, Oct. 2019. (plenary lecture) [postponed due to the Typhoon no.19]@@@@
29) Li, X., Hattori, A., Takahashi, S., Goto, Y., Harada, H., Kakeya, H. Inhibition of UCHL1 blocks proliferation and metastasis in HIF01 dependent tumor malignancy. 31th EORTC-NCI-AACR Symposium: International Conference on Molecular Targets and Cancer Therapeutics. Boston, MA, USA, Oct. 2019.@@@@
28) Kakeya, H, Kishimoto, A., Umeta, H., Imaizumi, A., Kanai, M. Development of an injectable water-soluble anticancer drug CMG for oxaliplatin-resistant colorectal cancer with KRAS mutation. 31th EORTC-NCI-AACR Symposium: International Conference on Molecular Targets and Cancer Therapeutics. Boston, MA, USA, Oct. 2019.@
27) Furutani, Y., Sudoh, M., Kakeya, H., Kojima, S. A small chemical compound CDM-3008 modulates cccDNA and suppresses HBV through induction of interferon-stimulated genes. 2019 International HBV Meeting. Melbourne, Australia, Oct. 2019.@@@@@
26) Kuranaga, T., Kakeya, H. Highly sensitive labeling reagents inspired by a scarce marine natural product. 10th Korea-Japan Chemical Biology Symposium. Ishikawa, Oct. 2019.@@@@@
25) Kanai, M., Kishimoto, A., Umeta, H., Imaizumi, A., Kakeya, H. Symposia 20 "Frontier in Molecular Target Therapy of Cancer": Development of a water-soluble prodrug CMG which inhibits proteasome activity through DYRK2 dependent manner. The 78th Annual Meeting of the Japanese Cancer Association, Kyoto, Sep. 2019. (invited)@@@@@
24) Li, X., Hattori, A., Goto, Y., Harada, H., Kakeya, H. Involvment of UCHL1 in the HIF-1-dependent tumor cell malignancy in 3D cell culture model. The 78th Annual Meeting of the Japanese Cancer Association, Kyoto, Sep. 2019.@@@@@
23) Š|’JGº, ‘q‰iŒ’Žj. Ž©‘R‚ÉŠw‚Ô–ò‚­‚è. ‹ž“s‘åŠwƒAƒJƒfƒ~ƒbƒNƒfƒC2019, ‹ž“s, 9ŒŽ, 2019.@@@@
22) ‚‹ŽL–Ÿ, —с@G–Ÿ, Poznaks, V. Š|’JGº. ’áŽ_‘f—U“±ˆöŽqHIF-1‘jŠQŠˆ«‚ð—L‚·‚éŠÂóƒfƒvƒVƒyƒvƒ`ƒhverucopeptin‚Ì‘S‡¬. ‘æ61‰ñ“V‘R—L‹@‰»‡•š“¢˜_‰ï, L“‡, 9ŒŽ, 2019.@@@@@
21) Kakeya, H. Frontier research on chemical communications unveils the mystery of life science. The 27th International Society of Heterocyclic Chemistry Congress. Kyoto, Sep. 2019. (invited)@@@@
20) “c‘º”ü”¿, ’†ì—Y‰î, ‘q‰iŒ’Žj, Š|’JGº. R‚ª‚ñ•šŽ¿ƒTƒbƒJƒƒXƒŠƒIƒŠƒhB‚ÌŽû‘©“I‘S‡¬Œ€‹†. ‘æ39‰ñ—L‹@‡¬ƒZƒ~ƒi[u–Ÿ“ú‚Ì—L‹@‡¬‚ð’S‚€l‚Ì‚œ‚߂Ɂv, ‘åã, 8ŒŽ, 2019.@@@@@
19) Š|’JGº. Ž©‘R‚ÉŠw‚ÔƒTƒCƒGƒ“ƒXuÀF ‰»ŠwƒRƒ~ƒ…ƒjƒP[ƒVƒ‡ƒ“‚̃tƒƒ“ƒeƒBƒAŒ€‹†. ‹ž“s‘åŠwƒI[ƒvƒ“ƒLƒƒƒ“ƒpƒX. ‹ž“s, 8ŒŽ, 2019.@@@@
18) ŒÃ’J@—T, ŒËŒû^—Žq, ^ˆä‰xŽq, ”óŒûËŽq, ¬—уJƒIƒ‹, {“¡³K, —é–ØŽ¡˜a, Š|’JGº, ¬“ˆ‘ˆê. cccDNA‚ð—}§‚·‚éƒCƒ“ƒ^[ƒtƒFƒƒ“—l’ᕪŽq‰»‡•šCDM-3008‚̍ì—p‹@\. ‘æ29‰ñRƒEƒBƒ‹ƒX—Ö@Šw‰ïŠwpW‰ïE‘‰ï, _“ސì, 7ŒŽ, 2019.@@@@@
17) ‹àˆä‰ëŽj, ŠÝ–{[O, ”~“c@“µ, ¡ò@Œú, Š|’JGº. ƒIƒLƒTƒŠƒvƒ‰ƒ`ƒ“’ïR«‚ÌKRAS‘å’°‚ª‚ñ‚ɑ΂·‚éCMG’ŽËÜ‚ð—p‚¢‚œV‹KŽ¡—Ö@‚ÌŠJ”­. ‘æ17‰ñ“ú–{—Տ°Žîᇊw‰ïŠwpW‰ï, ‹ž“s, 7ŒŽ, 2019.@@@@@
16) Š|’JGº. ”÷¶•šŠÔ‰»ŠwƒRƒ~ƒ…ƒjƒP[ƒVƒ‡ƒ“‚Ì—˜Šˆ—p‚É‚æ‚éV‹K¶•šŠˆ«ƒŠƒKƒ“ƒh‚ÌŠJ”­Œ€‹†. ‘æ19‰ñ“ú–{’`”’Ž¿‰ÈŠw‰ï”N‰ïE‘æ71‰ñ“ú–{×–E¶•šŠw‰ï‘å‰ï ‡“¯”NŽŸ‘å‰ï. •ºŒÉ, 6ŒŽ, 2019.@iµ‘ҍu‰‰j@@@@@@
15) Š|’JGº, Œ‘ºTˆê, ‘q‰iŒ’Žj, –ì’†Œ³—T, ˆä–{³Æ. ”÷¶•šŠÔ‰»ŠwƒRƒ~ƒ…ƒjƒP[ƒVƒ‡ƒ“‚Ì—‰ðE§Œä‚Æ—L—p¶•šŠˆ«ƒŠƒKƒ“ƒh‚ÌŠJ”­. VŠwp—̈挀‹†u‰»ŠwƒRƒ~ƒ…ƒjƒP[ƒVƒ‡ƒ“‚̃tƒƒ“ƒeƒBƒAvE‘æ5‰ñŒöŠJƒVƒ“ƒ|ƒWƒEƒ€, ‘åã, 6ŒŽ, 2019.@@@@@
14) ã–ìãđŸ, Š|’JGº, ã™Žu¬, ˆäŠÑW•ã, âV“¡@—T, ²“¡Œ’Œá, åŒŽN•¶. [‘wŠwK–@‚ÆPCA‰ðÍ‚ð‘g‚ݍ‡‚킹‚œƒPƒ~ƒJƒ‹ƒXƒy[ƒX‚̉Ž‹‰». VŠwp—̈挀‹†u‰»ŠwƒRƒ~ƒ…ƒjƒP[ƒVƒ‡ƒ“‚̃tƒƒ“ƒeƒBƒAvE‘æ5‰ñŒöŠJƒVƒ“ƒ|ƒWƒEƒ€, ‘åã, 6ŒŽ, 2019.@
13) Š|’JGº. uƒVƒ“ƒ|ƒWƒEƒ€E‚ª‚ñ‚ƏhŽå‚̉»ŠwƒRƒ~ƒ…ƒjƒP[ƒVƒ‡ƒ“‚Ì—‰ð‚Ɛ§Œäv. …—n«ƒvƒƒhƒ‰ƒbƒOŒ^•ªŽq•W“IR‚ª‚ñÜCMG‚ÌŠJ”­Œ€‹†. ‘æ23‰ñ“ú–{‚ª‚ñ•ªŽq•W“IŽ¡—Êw‰ïŠwpW‰ï. ‘åã, 6ŒŽ, 2019. iµ‘ҍu‰‰j@@@@@
12) “c‘º”ü”¿, ’†ì—Y‰î, ‘q‰iŒ’Žj, Š|’JGº. R‚ª‚ñŠˆ«‚ð—L‚·‚é”÷¶•š‘ãŽÓŽY•šƒTƒbƒJƒƒXƒŠƒIƒŠƒhB‚Ì‘S‡¬Œ€‹†. ‘æ86‰ñ“ú–{•ªÍ‰»Šw‰ï—L‹@”÷—Ê•ªÍŒ€‹†§’k‰ïE‘æ110‰ñŒv‘ªŽ©“®§ŒäŠw‰ï—ÍŠw—ÊŒv‘ª•”‰ï ‘æ36‰ñ‡“¯ƒVƒ“ƒ|ƒWƒEƒ€. ‹ž“s, 6ŒŽ, 2019.@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@
11) ‹àŽqŒ«‰î, ’·”ö–ì‰f‰Ô, •ž•”@–Ÿ, Š|’JGº. ’áŽ_‘f—U“±ˆöŽqiHIFj‘jŠQ‰»‡•šverucopeptin‚̐¶‡¬ˆâ“`ŽqƒNƒ‰ƒXƒ^[‚Ì“¯’è‚ƐV‹K—Þ‰‘Ì‚Ì’Tõ. ‘æ86‰ñ“ú–{•ªÍ‰»Šw‰ï—L‹@”÷—Ê•ªÍŒ€‹†§’k‰ïE‘æ110‰ñŒv‘ªŽ©“®§ŒäŠw‰ï—ÍŠw—ÊŒv‘ª•”‰ï ‘æ36‰ñ‡“¯ƒVƒ“ƒ|ƒWƒEƒ€. ‹ž“s, 6ŒŽ, 2019.@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@
10) Š|’JGº. uƒVƒ“ƒ|ƒWƒEƒ€E‰»ŠwƒRƒ~ƒ…ƒjƒP[ƒVƒ‡ƒ“‚̃tƒƒ“ƒeƒBƒAv. ”÷¶•šŠÔ‰»ŠwƒRƒ~ƒ…ƒjƒP[ƒVƒ‡ƒ“‚Ì—˜Šˆ—p‚É‚æ‚éV‹K—L—p¶•šŠˆ«ƒŠƒKƒ“ƒh‚ÌŠJ”­Œ€‹†. ‘æ19‰ñ“ú–{’`”’Ž¿‰ÈŠw‰ï”N‰ïE‘æ71‰ñ“ú–{×–E¶•šŠw‰ï ‡“¯”NŽŸ‘å‰ï. •ºŒÉ, 6ŒŽ, 2019. iµ‘ҍu‰‰j@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@
9) ŒÃ’J@—T, ŒËŒû^—Žq, ^ˆä‰xŽq, ”óŒûËŽq, {“¡³K, —é–ØŽ¡˜a, Š|’JGº, ¬“ˆ‘ˆê. ƒCƒ“ƒ^[ƒtƒFƒƒ“—l‚ÌŠˆ«‚ðŽ‚Â’á•ªŽq‰»‡•šCDM-3008‚̍RHBVŠˆ«‚̉ðÍ. ‘æ26‰ñŠÌ×–EŒ€‹†‰ï. ‰¡•l, 5ŒŽ, 2019.@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@
8) Š|’JGº. uƒVƒ“ƒ|ƒWƒEƒ€E‚ª‚ñ”÷¬ŠÂ‹«‚Ì—‰ð‚Æ‚»‚̍Ž•ž‚ÉŒü‚¯‚œ–òŠw“IƒAƒvƒ[ƒ`‚Ƃ́HHIF-1ƒ¿‚Ì—‰ð‚Ɛ§Œä‚ÉŒü‚¯‚āv. ’áŽ_‘f‰ž“šƒVƒOƒiƒ‹‚ð•W“I‚Æ‚µ‚œ‘n–òƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[. “ú–{–òŠw‰ï‘æ139”N‰ï. ç—t, 3ŒŽ, 2019. iµ‘ҍu‰‰j@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@
7) Š|’JGº. ’†’·Šúƒe[ƒ}ƒVƒ“ƒ|ƒWƒEƒ€u¶–œ‰ÈŠw‚É‚š‚¯‚镪Žq‰»Šw‚̃vƒŒƒ[ƒ“ƒXv. ‰»ŠwƒRƒ~ƒ…ƒjƒP[ƒVƒ‡ƒ“‚ªD‚è‚È‚·¶–œ‰ÈŠw. “ú–{‰»Šw‰ï‘æ99t‹G”N‰ïi2019j. _ŒË, 3ŒŽ, 2019. iµ‘ҍu‰‰j
6) ó…r•œ, ”öè‘Ÿ˜Y, Œ‘ºTˆê, Š|’JGº, ”ö’‡GN. •¡‡”|—{‚É‚š‚¯‚éStreptomyces sp. HEK616‚É‚æ‚é5aTHQs‚̐¶ŽY‹@\, “ú–{”_Œ|‰»Šw‰ï2019”N“x‘å‰ï. “Œ‹ž, 3ŒŽ, 2019.
5) Kakeya, H. Development of cryptic antifungal 5aTHQs targting cell membrane signaling. Asian Chemical Biology Initiative (ACBI) 2019 Yangon Meeting. Yangon, Myanmer, Jan. 2019. (invited)@@@@@@@@@@@@@@@@@@@@
4) Š|’JGº. uƒVƒ“ƒ|ƒWƒEƒ€E“V‘R•š‘n–ò`“ú–{‚Ì‹­‚݂𐶂©‚µ‚œV’ª—¬`v@“V‘R•š‘n–ò‚Ì•œŒ ‚ðŠú‚µ‚āF”÷¶•šŠÔ‰»ŠwƒRƒ~ƒ…ƒjƒP[ƒVƒ‡ƒ“‚Ì—˜Šˆ—p. ‘æ402‰ñCBIŠw‰ïiî•ñŒvŽZ‰»Šw¶•šŠw‰ïju‰‰‰ï. “Œ‹ž, 1ŒŽ, 2019. iµ‘ҍu‰‰j@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@
3) Kakeya, H., Takahashi, N., Kishimoto, A., Imaizumi, A., Kanai, M. Development of an innovative water-soluble anticancer drug, curcumin mono-beta-D-glucuronide (CMG). The 1st International Symposium on Chemical Communication (ISCC2019). Tokyo, Jan. 2019.@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@
2) Nonaka, M., Fukuda, M.N., Kakeya, H. Rapid screening of antibody-binding peptides by combination of T7 phage display and next-generation sequencing technologies. The 1st International Symposium on Chemical Communication (ISCC2019). Tokyo, Jan. 2019.@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@
1) Jiang, Y., Lu, S., Hirai, G., Kato, T., Onaka, H., Kakeya, H. Towards the development of chemical communication molecules among microbes. The 1st International Symposium on Chemical Communication (ISCC2019). Tokyo, Jan. 2019.@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@

2018

33) Kakeya, H., Kishimoto, A., Imaizumi, A., Kanai, M. Development of a synthetic water-soluble curcumin mono-beta-D-glucuronide (CMG), as an innovative anticancer prodrug targeting KRAS-NF-kappaB signaling pathway. 30th EORTC-NCI-AACR Symposium: International Conference on Molecular Targets and Cancer Therapeutics. Dublin, Ireland, Nov. 2018.
32) Nonaka, M., Kakeya, H., Fukuda, M. Drug delivery to malignant brain tumor by a peptide specific to Annexin A1. 30th EORTC-NCI-AACR Symposium: International Conference on Molecular Targets and Cancer Therapeutics. Dublin, Ireland, Nov. 2018.
31) Š|’JGº. ˆã–ò•iƒV[ƒh•ªŽq‚Ì‘œ—l«‘no‚ƍזE“à•W“I’TõE“¯’è. ‹ž‘åƒeƒbƒNƒtƒH[ƒ‰ƒ€. “Œ‹ž, 10ŒŽ, 2018. iµ‘ҍu‰‰j
30) Jiang, Y. L., Lu, S., Hirai, G., Kato, T., Onaka, H., Kakeya, H. Enhancement of saccharothriolides production and discovery of new derivatives by combined culture of a rare actinomycete Saccharothrix sp. and Tsukamurella sp. The 22th Symposium on Development and Application of Naturally Occurring Drug Materials. Kumamoto, Oct. 2018.
29) Œ‘ºTˆê, ™ŽR—Ž‰î, ’‡’J’G, ”öè‘Ÿ˜Y, ó…r•œ, ”ö’‡GN, Š|’JGº. ”÷¶•š‚Ì•¡‡”|—{‚Å“Ÿ‚ç‚ê‚é5aTHQ‚Ì–Œe˜a«‚Ɛ¶•šŠˆ«. ‘æ60‰ñ“V‘R—L‹@‰»‡•š“¢˜_‰ï. •Ÿ‰ª, 9ŒŽ, 2018.
28) ŠâŸºDŽ¡, ²“¡—º, ù–ì—T‰î, ¬ŒTŒá, –ìŒû³Žk, Š|’JGº, ’·“c—T”V, Š’ŒŽ÷. ƒAƒ|ƒg[ƒVƒX—U“±Šˆ«“V‘R•šcytotrienin A‚̍‡¬Œ€‹†. ‘æ60‰ñ“V‘R—L‹@‰»‡•š“¢˜_‰ï. •Ÿ‰ª, 9ŒŽ, 2018.
27) Š|’JGº, –ì’†Œ³—T, ‘q‰iŒ’Žj. “V‘R•š‘n–òƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[. ‹ž“s‘åŠwƒAƒJƒfƒ~ƒbƒNƒfƒC2018, ‹ž“s, 9ŒŽ, 2018.
26) ‚‹ŽçŠG, Shan Lu, Yulu Jiang, “Œ Ž‹Å, Œ‘ºTˆê, •ž•” –Ÿ, Š|’JGº. ‘æ91‰ñ“ú–{¶‰»Šw‰ï‘å‰ï. ‹ž“s, 9ŒŽ, 2018.
25) ŒŒŽ‘ñ^, •ž•” –Ÿ, Š|’JGº. Calpain7‚̍זE“à‹ÇÝ‚̉ðÍ. ‘æ91‰ñ“ú–{¶‰»Šw‰ï‘å‰ï. ‹ž“s, 9ŒŽ, 2018.
24) •Ÿ‰ªŒ[‘Ÿ, •ž•” –Ÿ, Š|’JGº. y‘f”œ‰ž‘¬“x˜_“I‰ðÍ‚ð—p‚¢‚œ’Eƒ†ƒrƒLƒ`ƒ“‰»y‘fUSP47‚ÌC––’[—̈æ‚Ì‹@”\‰ðÍ. ‘æ91‰ñ“ú–{¶‰»Šw‰ï‘å‰ï. ‹ž“s, 9ŒŽ, 2018.
23) Š|’JGº. “V‘R•š‘n–òƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[`•úü‹Û‚É–£‚¹‚ç‚ê‚ā`. 2018”N“xi‘æ33‰ñj“ú–{•úü‹ÛŠw‰ï‘å‰ï. “Œ‹ž, 9ŒŽ, 2018. iµ‘ҍu‰‰j
22) ¶“cŽÀ¹, ˆÉ“¡ˆ€—, Œ‘ºTˆê, ‹g“c –«, Š|’JGº. ‘œŠu•ÇŒ`¬‚â×–EL’·‚É‚š‚¯‚éƒXƒtƒBƒ“ƒSŽ‰Ž¿‚̏d—v«. y•êˆâ“`ŠwƒtƒH[[ƒ‰ƒ€‘æ51‰ñŒ€‹†•ñ‰ï. •Ÿ‰ª, 9ŒŽ, 2018. (ƒ|ƒXƒ^[Ü‚ðŽóÜ)
21) Š|’JGº. Ž©‘R‚ÉŠw‚ÔƒTƒCƒGƒ“ƒXuÀF ‰»ŠwƒRƒ~ƒ…ƒjƒP[ƒVƒ‡ƒ“•ªŽq‚Ì“ä‚É”—‚é. ‹ž“s‘åŠwƒI[ƒvƒ“ƒLƒƒƒ“ƒpƒX. ‹ž“s, 8ŒŽ, 2018.
20) Š|’JGº. ”_–ò‚Ì‘n»EŒ€‹†ŠJ”­“®Œü‚Ɛ»Ü‰»‹ZpƒZƒ~ƒi[FV‹K”_–ò‚ÌŠJ”­‚ðŽuŒü‚µ‚œƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[Œ€‹†. ƒV[ƒGƒ€ƒV[o”ŃZƒ~ƒi[. “Œ‹ž, 7ŒŽ, 2018.iµ‘ҍu‰‰j
19) Jiang, Y.L., Lu, S., Hirai, G., Kato, T., Onaka, H., Kakeya, H. Enhancement of saccharothriolide (STLs) production by combined-culture of Saccharothrix sp. and Tsukamurella sp. The 29th Meeting on Discovery and Development of New Drugs. Shizuoka, Jul. 2018.
18) “c‘º—S–ç, Shan Lu, “ˆ“cŽ, Š|’JGº. ’áŽ_‘f—U“±ˆöŽqiHIFsjŠˆ«‰»•šŽ¿‚Ì’P—£E\‘¢Œˆ’è‚ƍì—p‹@˜‰ðÍ. ‘æ29‰ñV–ò‘n¬’k˜b‰ï. Ã‰ª, 7ŒŽ, 2018.
17) Š|’JGº. “V‘R•š‘n–òƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[‚Ì‘çŒí–¡. ‘æ53‰ñ“V‘R•š‰»Šw’k˜b‰ï. ‘åã, 7ŒŽ, 2018.iµ‘ҍu‰‰j
16) ’r“à‘Pé, Cheng-Quin Pan, ¶“cŽÀ¹, Œ‘ºTˆê, Š|’JGº. ¶‘Ì–ŒƒVƒOƒiƒ‹‚ɍì—p‚·‚é“V‘R•š‚Ì’TõŒ€‹†. ‘æ53‰ñ“V‘R•š‰»Šw’k˜b‰ï. ‘åã, 7ŒŽ, 2018.
15) ˆÉ“¡k¢, ‘q‰iŒ’Žj, Š|’JGº, ˜e–{•qK. ƒZƒIƒlƒ‰ƒ~ƒhF‚̍‡¬Œ€‹†. ‘æ53‰ñ“V‘R•š‰»Šw’k˜b‰ï. ‘åã, 7ŒŽ, 2018.
14) Š|’JGº, Œ‘ºTˆê, ‘q‰iŒ’Žj, –ì’†Œ³—T, ˆä–{³Æ. ”÷¶•šŠÔ‰»ŠwƒRƒ~ƒ…ƒjƒP[ƒVƒ‡ƒ“‚Ì—‰ð‚Æ—L—p¶•šŠˆ«ƒŠƒKƒ“ƒh‚ÌŠJ”­. VŠwp—̈挀‹†u‰»ŠwƒRƒ~ƒ…ƒjƒP[ƒVƒ‡ƒ“‚̃tƒƒ“ƒeƒBƒAvE‘æ3‰ñŒöŠJƒVƒ“ƒ|ƒWƒEƒ€. “Œ‹ž, 6ŒŽ, 2018.
13) Š|’JGº. u‰»ŠwƒRƒ~ƒ…ƒjƒP[ƒVƒ‡ƒ“‚̃tƒƒ“ƒeƒBƒAv‚ð‹N“_‚É‚µ‚œ‘n–òƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[. VŠwp—̈挀‹†uŽ‰Ž¿ƒNƒIƒŠƒeƒB‚ª‰ð‚«–Ÿ‚©‚·¶–œŒ»Ûv‘æ4‰ñ—̈æ‰ï‹c. •ºŒÉ, 6ŒŽ, 2018. i“Á•Êu‰‰j
12) ŒÃ’J@—T, Š|’JGº, ¬“ˆ‘ˆê. ƒ[ƒNƒVƒ‡ƒbƒvuBŒ^ŠÌ‰ŠV‹KŽ¡—Öò‚Ì’Tõ‚ÌŒ»óvFƒhƒ‰ƒbƒOƒtƒŠ[‚ÌŽÀŒ»‚ð–ÚŽw‚µ‚œcccDNA—}§ÜCDM-3008‚ƃGƒ“ƒeƒJƒrƒ‹‚Æ‚Ì•¹—p‚É‚æ‚éHBVÄŠˆ«‰»‚Ì—}§. ‘åã, 6ŒŽ, 2018. i“Á•Êu‰‰j
11) Lu, S., Nishimura, S., Ito, M., Kato, T., Kakeya, H. Discovery of pre-saccharothriolide X from the rare actinomycet Saccharothrix sp. The 13th Annual Meeting of Japanese Society for Chemical Biology, Tokyo, Jun. 2018.
10) Kakeya, H. Microbial metabolites targeting microenvironment: a cell membrane sigaling modulator and a hypoxia-response modulator. The 9th Japan-Korea chemical biology symposium, Incheon, Korea, May, 2018. (invited)
9) Ogawa, Y., Kakeya, H. Screening of sensitizers derived from microbial metabolites to induce apoptosis in pancreatic cancer cells. The 9th Japan-Korea chemical biology symposium, Incheon, Korea, May, 2018.
8) Nonaka, M., Kakeya, H., Fukuda, M. Identification of binding peptides against IgE from human myeloma U266 cells. The 9th Japan-Korea chemical biology symposium, Incheon, Korea, May, 2018.
7) Li, X.B., Goto, Y., Hattori, A., Harada, H., Kakeya, H. Study on the UCHL1-HIF-1 axis toward development of molecular targeted anticancer drugs. The 22th Annual Meeting of the Japanese Association for Molecular Target Therapy of Cancer (JAMTTC), Tokyo, May, 2018.
6) Kanai, M., Imaizumi, A., Kakeya, H. Development of a water-soluble curcumin monoglucronide (CMG) as a novel anticancer prodrug targeting KRAS-NF-kappa B signaling pathway. Global Academic Programs (GAP) conference, Stockholm, Sweden, May, 2018. (invited)
5) Š|’JGº. u’†’·ŠúŠé‰æEƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[Œ€‹†‰Á‘¬‚Ì‚œ‚߂̐¶•šŠˆ«•ªŽq‚Ì”­Œ©í—ªv\”÷¶•šŠÔ‰»ŠwƒRƒ~ƒ…ƒjƒP[ƒVƒ‡ƒ“‚Ì“ä‚É’§‚ށ\. “ú–{‰»Šw‰ï‘æ98t‹G”N‰ï. ç—t, 3ŒŽ, 2018. iµ‘ҍu‰‰j
4) ™èr•¶, ‚{N–Ÿ, •ž•” –Ÿ, ¬“ˆ‘ˆê, Š|’JGº. TGF-ƒÀƒVƒOƒiƒ‹“`’B‘jŠQÜKUSC-Y244‚ÍTGF-ƒÀ‚É‚æ‚éã”çŠÔ—t“]Š·‚ð—}§‚·‚é. “ú–{–òŠw‰ï‘æ138”N‰ï, ‹à‘ò, 3ŒŽ, 2018.
3) Š|’JGº. uƒVƒ“ƒ|ƒWƒEƒ€F‚±‚ê‚©‚ç‚Ì“V‘R•šƒTƒCƒGƒ“ƒXv\ƒPƒ~ƒJƒ‹ƒXƒy[ƒXŠg[í—ªF”÷¶•š•¡‡”|—{–@‹y‚ÑPDSS (Precurso-Directed in situ Synthesis)–@\, “ú–{”_Œ|‰»Šw‰ï2018”N“x‘å‰ï. –ŒŒÃ‰®, 3ŒŽ, 2018. iµ‘ҍu‰‰j
2) Š|’JGº. ”÷¶•šŠÔ‰»ŠwƒRƒ~ƒ…ƒjƒP[ƒVƒ‡ƒ“‚Ì—˜Šˆ—p‚É‚æ‚éƒPƒ~ƒJƒ‹ƒXƒy[ƒXŠg[í—ª. VŠwp—̈挀‹†u‰»ŠwƒRƒ~ƒ…ƒjƒP[ƒVƒ‡ƒ“‚̃tƒƒ“ƒeƒBƒAvE‘æ2‰ñŒöŠJƒVƒ“ƒ|ƒWƒEƒ€. ‹ž“s, 2ŒŽ, 2018. iµ‘ҍu‰‰j
1) Lu, S., Nishimura, S., Ito, M., Kato, T., Kakeya, H. Expansion of chemical space in saccharothriolides: Precursor-directed in situ synthesis (PDSS) in a rare actinomycete Saccharothrix sp. Natural Product Discovery & Development in the Genomic Era (Natural Products 2018), Clearwater, FL, USA. Jan. 2018.

2017

26) Š|’JGº. ‘n”_–òƒCƒmƒx[ƒVƒ‡ƒ“‚ð‘n”­‚·‚éƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[•û—ª. ”_–òƒfƒUƒCƒ“Œ€‹†‰ïiŽåÃF“ú–{”_–òŠw‰ïE”_–òƒfƒUƒCƒ“Œ€‹†‰ïj. “Œ‹ž, 11ŒŽ, 2017. iµ‘ҍu‰‰j
25) ¡ò Œú, ‚‹ŽL–Ÿ, Œõ‹à‰pé, ‹àˆä‰ëŽj, ‹Ž–{ ³, –q–ì—IŽ¡, ’ÓcF”Í, Š|’JGº. ‹@”\«H•i‘fÞ‚̈ã–ò•i‚Ö‚Ì“WŠJ‚ð–ÚŽw‚µ‚œ‘n–òƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[. ‘æ7‰ñH•i–òŠwƒVƒ“ƒ|ƒWƒEƒ€. ‹ž“s, 10ŒŽ, 2017. iµ‘ҍu‰‰j
24) ‚‹ŽL–Ÿ, —Ñ G–Ÿ, Poznaks, V., Š|’JGº. ˆã–ò‰»Šw“I“WŠJ‚ðŽwŒü‚µ‚œverucopeptin‚Ì‘S‡¬Œ€‹†. ‘æ35‰ñƒƒfƒBƒVƒiƒ‹ƒPƒ~ƒXƒgƒŠ[ƒVƒ“ƒ|ƒWƒEƒ€. –ŒŒÃ‰®, 10ŒŽ, 2017.
23) Furutani, Y., Toguchi, M., kakeya, H., Kojima, S. Combinatorial treatment of CDM/iCDM and entecavir for efficient suppression of cccDNA. 2017 International HBV Meeting: The Molecular Biology of Hepatitis B viruses, Washington, DC, USA. Sep. 2017.
22) Œ‘ºTˆê, ‹g‘º Ê, ™ŽR—Ž‰î, Š|’JGº. “V‘R—L‹@‰»‡•š‚̍\‘¢‰ðÍ‚ÆNMRƒVƒOƒiƒ‹‚̏d•¡. ‘æ18‰ñNMRŒ€‹†‰ï. ˜a‰ÌŽR, 9ŒŽ, 2017. iµ‘ҍu‰‰j
21) ¶“cŽÀ¹, ˆÉ“¡ˆ€—, Œ‘ºTˆê, Š|’JGº. ƒXƒtƒBƒ“ƒSŽ‰Ž¿‚Ì‹@”\‰ð–Ÿ‚ð–ÚŽw‚µ‚œ‰»Šwˆâ“`Šw“I‰ðÍ.FƒGƒLƒmƒ}ƒCƒVƒ“—Þ‚ÌŽæ“Ÿ‚Æ‚»‚Ì•\Œ»Œ^. y•êˆâ“`ŠwƒtƒH[ƒ‰ƒ€‘æ50‰ñŒ€‹†•ñ‰ï. “Œ‹ž, 9ŒŽ, 2017.
20) Œ‘ºTˆê, “¿‘q«l, Š|’JGº, Œ‰i–ÎŽ÷, ‘å‹÷³Žq, ¶£‹`‹v, Carvalho, S., Cortes, J., Ribas, J. ƒXƒeƒ[ƒ‹‚ð•W“I‚É‚·‚éR^‹Û‰»‡•šƒZƒIƒlƒ‰ƒ~ƒh‚É‚æ‚é×–E•ÇˆÙí. y•êˆâ“`ŠwƒtƒH[ƒ‰ƒ€‘æ50‰ñŒ€‹†•ñ‰ï. “Œ‹ž, 9ŒŽ, 2017.
19) ‰º‘º‘sl, ”öè‘Ÿ˜Y, ™ŽR—Ž‰î, Œ‘ºTˆê, ó…r•œ, Š|’JGº, ”ö’‡GN. •¡‡”|—{‚É‚æ‚Á‚жŽY‚³‚ê‚éƒeƒgƒ‰ƒqƒhƒƒLƒmƒŠƒ“‰»‡•š‚̉ðÍ. ‘æ32‰ñ“ú–{•úü‹ÛŠw‰ï‘å‰ï, ’·–ì, 9ŒŽ, 2017.
18) Š|’JGº. Ž©‘R‚ÉŠw‚ÔƒTƒCƒGƒ“ƒXuÀF”÷¶•šŠÔ‰»ŠwƒRƒ~ƒ…ƒjƒP[ƒVƒ‡ƒ“‚Ì“ä‚É”—‚é. ‹ž“s‘åŠwƒI[ƒvƒ“ƒLƒƒƒ“ƒpƒX. ‹ž“s, 8ŒŽ, 2017.
17) ‹àˆä‰ëŽj, ¬àV “µ, ¡ò Œú, ‚‹ŽL–Ÿ, Š|’JGº. ƒ[ƒNƒVƒ‡ƒbƒvuƒAƒJƒfƒ~ƒA”­R‚ª‚ñ–òŠJ”­‚̐i“WvFƒvƒƒhƒ‰ƒbƒOŒ^ƒNƒ‹ƒNƒ~ƒ“‚ð—p‚¢‚œV‹KR‚ª‚ñ–ò‚ÌŠJ”­. ‘æ15‰ñ“ú–{—Տ°Žîᇊw‰ïŠwpW‰ï. •ºŒÉ, 7ŒŽ, 2017.
16) ¬ì‚Í‚é‚©, —›@á•X, •ž•”@–Ÿ, Œã“¡—eŽq, XéêÍ‘ã, •œ‰ªáÁŠ°, ŒŽ“c@_, Š|’JGº. •ªŽq•W“IR‚ª‚ñÜŠJ”­‚ðŽwŒü‚µ‚œ’Eƒ†ƒrƒLƒ`ƒ“‰»y‘fUCHL1‘jŠQÜ‚Ì’TõŒ€‹†. ‘æ28‰ñV–ò‘n¬’k˜b‰ïuŽŸŠ³‚Æ‘n–ò‚̃Cƒmƒx[ƒVƒ‡ƒ“v. Ã‰ª, 7ŒŽ, 2017.
15) ¶“cŽÀ¹, ˆÉ“¡ˆ€—, “¡“cq•œ, Œ‘ºTˆê, Š|’JGº. ×–E–ŒŽ‰Ž¿‚ð•W“I‚Æ‚·‚鉻‡•š‚̃XƒNƒŠ[ƒjƒ“ƒO‹y‚Ñ‚»‚ÌŠˆ«•]‰¿. ‘æ28‰ñV–ò‘n¬’k˜b‰ïuŽŸŠ³‚Æ‘n–ò‚̃Cƒmƒx[ƒVƒ‡ƒ“v. Ã‰ª, 7ŒŽ, 2017.(—DG”­•\Üi§—ãÜj‚ðŽóÜ)
14) Lu, S., Nishimura, S., Ito, M., Kato, T., Kakeya, H. Novel natural products, saccharothriolides, from rare actinomycete Saccharothrix sp. and precursor-directed in situ synthesis (PDSS) of thier analogs. The 10th Anniversary Symposium of Division of Bioinformatics and Chemical Genomics, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, July, 2017.
13) ‹àŽqŒ«‰î, ’|’† Œd, ’·”ö–ì‰f‰Ô, Îì•¶—m, ”g‘œ–ì˜aŽ÷, ŒÜ\—’‰ë”V, Š|’JGº. ƒPƒ~ƒJƒ‹ƒXƒy[ƒXŠg[‚ðŽwŒü‚µ‚œ¶‡¬HŠw“IŒ€‹†. ‹ž“s‘åŠw‘åŠw‰@–òŠwŒ€‹†‰Èˆã–ò‘n¬î•ñ‰ÈŠwêU10Žü”N‹L”OƒVƒ“ƒ|ƒWƒEƒ€. ‹ž“s, 7ŒŽ, 2017.
12) •Ÿ‰ªŒ[‘Ÿ, “ˆ“cŽ, •ž•” –Ÿ, Š|’JGº. ’Eƒ†ƒrƒLƒ`ƒ“‰»y‘fUSP47‚̃|ƒŠƒ†ƒrƒLƒ`ƒ“œÁ‰»‹@\‚̉𖟂ƑjŠQÜ’TõŒn‚̍\’z. ‹ž“s‘åŠw‘åŠw‰@–òŠwŒ€‹†‰Èˆã–ò‘n¬î•ñ‰ÈŠwêU10Žü”N‹L”OƒVƒ“ƒ|ƒWƒEƒ€. ‹ž“s, 7ŒŽ, 2017.
11) ‚‹ŽL–Ÿ, —с@G–Ÿ, Viktors Poznacks, Š|’JGº. ’áŽ_‘f—U“±ˆöŽqiHIFsj‘jŠQÜŠJ”­‚ðŽwŒü‚µ‚œverucopeptin‚Ì‘S‡¬Œ€‹†. ‹ž“s‘åŠw‘åŠw‰@–òŠwŒ€‹†‰Èˆã–ò‘n¬î•ñ‰ÈŠwêU10Žü”N‹L”OƒVƒ“ƒ|ƒWƒEƒ€. ‹ž“s, 7ŒŽ, 2017.
10) Š|’JGº. ”÷¶•š•¡‡”|—{–@‚Ì—˜Šˆ—p‚É‚æ‚é‘n–òƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[. ‘æ12‰ñ‰»Šw¶‘ÔŠwŒ€‹†‰ï. ”ŸŠÙ, 6ŒŽ, 2017. iµ‘ҍu‰‰j
9) ŒÃ’J@—T, Š|’JGº, ¬“ˆ‘ˆê. ƒVƒ“ƒ|ƒWƒEƒ€uBŒ^ŠÌ‰ŠŒ€‹†‚̐V“WŠJvFcccDNA—}§ÜCDM/iCDM‚ƃGƒ“ƒeƒJƒrƒ‹‚Æ‚Ì•¹—pŒø‰Ê‚̉ðÍ. ‘æ53‰ñ“ú–{ŠÌ‘ŸŠw‰ï‘‰ï. L“‡, 6ŒŽ, 2017.
8) Lu, S., Nishimura, S., Ito, M., Kato, T., Kakeya, H. Generation of saccharothriolide analogs by precursor-directed in situ synthesis (PDSS) and their SAR study. The 12th Annual Meeting of Japanese Society for Chemical Biology, Sapporo, June, 2017.
7) Œ‘ºTˆê, ˆÉ“¡ˆ€—, ‚‹ŽL–Ÿ, Š|’JGº. ƒTƒ|ƒjƒ“‚ƃXƒeƒ[ƒ‹‚Ì•ªŽqŠÔ‘ŠŒÝì—p‚É‚š‚¯‚é’Y‰»…‘f•œ–ʂƐ…Ž_Šî‚̏d—v«. “ú–{ƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[Šw‰ï ‘æ12‰ñ”N‰ï, ŽD–y, 6ŒŽ, 2017.
6) Š|’JGº. Ž©‘R‚ÉŠw‚сAŒŽ—‚ð•R‰ð‚«A‚­‚·‚è‚ð‘n‚é. “ú–{ŠwpU‹»‰ïiJSPSju“ú–{‚É‚š‚¯‚éƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[‚̐V“WŠJv‚ÉŠÖ‚·‚éŽYŠw‹Š—ÍŒ€‹†ˆÏˆõ‰ïiJSPS‘æ189ˆÏˆõ‰ïjEH29”N“x‘æ1‰ñ’è—á‰ï, “Œ‹ž, 5ŒŽ, 2017.iµ‘ҍu‰‰j
5) Li, X.B., Takahashi, S., Hattori, A., Goto, Y., Morinobu, A., Hiraoka, M., Harada, H., Kakeya, H. Chemical biology research on the UCHL1-HIFs axis toward development of molecular targeted anticancer drugs. SKO Symposium 2017 (Joint Symposium 2017 of Seoull Univ., Kyoto Univ., and Osaka Univ.), Osaka, May, 2017.
4) —›@á•X, •ž•”–Ÿ, Œã“¡—eŽq, XéêÍ‘ã, , •œ‰ªáÁŠ°, ŒŽ“c@_, Š|’JGº. ‘åŠw‰@¶ƒVƒ“ƒ|ƒWƒEƒ€u–òŠw‚ª‚ñŒ€‹†‚Ì”­“W‚Æ–¢—ˆ‚ðæ“±‚·‚éŽáŽè‚ª‚ñŒ€‹†ŽÒ‚Ì’§ívFUCHL1-HIFŠˆ«‰»Œo˜H‚ð•W“I‚Æ‚µ‚œ•ªŽq•W“IR‚ª‚ñÜŠJ”­Œ€‹†. “ú–{–òŠw‰ï‘æ137”N‰ï. å‘ä, 3ŒŽ, 2017. iµ‘ҍu‰‰j
3) —с@‹±•œ, ‚‹ŽL–Ÿ, ’†ì—Y‰î, ŒËŒû^—Žq, ²“¡—T”ü, ŒÃ’J@—T, ¬“ˆ‘ˆê, Š|’JGº. V‹KBŒ^ŠÌ‰ŠŽ¡—Öò‘n»‚ÉŒü‚¯‚œCDMs‚̍\‘¢Šˆ«‘ŠŠÖŒ€‹†. “ú–{–òŠw‰ï‘æ137”N‰ï. å‘ä, 3ŒŽ, 2017.
2) Š|’JGº. uƒVƒ“ƒ|ƒWƒEƒ€F”_Œ|‰»Šw‚©‚ç”­M‚·‚鎟¢‘ãŒ^“V‘R•š‰»Šwv\ƒAƒJƒfƒ~ƒA‘n–ò‚É‚š‚¯‚é•\Œ»Œ^ƒXƒNƒŠ[ƒjƒ“ƒO‚ÆŽŸ¢‘ã“V‘R•š‰»Šw\. “ú–{”_Œ|‰»Šw‰ï2017”N“x‘å‰ï. ‹ž“s, 3ŒŽ, 2017. iµ‘ҍu‰‰j
1) Š|’JGº. ‘n–òƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[Œ€‹†•û—ªF•\Œ»Œ^ƒXƒNƒŠ[ƒjƒ“ƒO‚ƃV[ƒh•ªŽqŠJ”­. ƒrƒbƒOƒf[ƒ^‹ì“®Œ^‘n–òƒVƒXƒeƒ€Œ€‹†‹’“_E‘æ3‰ñƒVƒ“ƒ|ƒWƒEƒ€. Œcœä‹`m‘åŠw. ‰¡•l, 3ŒŽ, 2017. iµ‘ҍu‰‰j

2016

24) —›@á•X, Œã“¡—eŽq, •ž•”–Ÿ, •œ‰ªáÁŠ°, ŒŽ“c@_, Š|’JGº. V‹K•ªŽq•W“IR‚ª‚ñÜŠJ”­‚ðŽwŒü‚µ‚œUCHL1-HIFŠˆ«‰»Œo˜H‘jŠQÜƒXƒNƒŠ[ƒjƒ“ƒOŒn‚̍\’z. ‘æ75‰ñ“ú–{ŠàŠw‰ïŠwp‘‰ï. ‰¡•l, 10ŒŽ, 2016.
23) Œ‘ºTˆê, ™ŽR—Ž‰î, ’‡’J’G, ”öè‘Ÿ˜Y, ó…r•œ, ”ö’‡GN, Š|’JGº. ”÷¶•š‚Ì•¡‡”|—{‚Å“Ÿ‚ç‚ê‚é5aTHQ‚Æstreptoaminal‚̍\‘¢‚ƍ\‘¢. ‘æ21‰ñ“V‘R–ò•š‚ÌŠJ”­‚Ɖž—pƒVƒ“ƒ|ƒWƒEƒ€. ç—t, 10ŒŽ, 2016.iµ‘ҍu‰‰j
22) Kojima, S., Furutani, Y., Kakeya, H. Screening of novel cccDNA modulator compounds, iCDMs.The 2016 International HBV Meeting: The Molecular Biology of Hepatitis B Viruses. Seuol, Korea, Sep. 2016.
21) Îì•¶—m, ¡–ì@ãÄ, Š}ˆäº‘Ÿ, —é–ØŒ’—T, “°‘O@’Œ, Š|’JGº. ”ñƒŠƒ{ƒ\[ƒ€«ƒyƒvƒ`ƒh‡¬y‘f‚Ì‘I‘ð“Iƒ‰ƒxƒ‹‰»‹Zp‚ÌŠJ”­‚Ɛv‘¬‹@”\‰ðÍƒVƒXƒeƒ€‚̍\’z. ‘æ58‰ñ“V‘R—L‹@‰»‡•š“¢˜_‰ï. å‘ä, 9ŒŽ, 2016.
20) Œ–{‘אM, “ú”ä–ì˜a_, ¢‰i‰ëO, Š|’JGº, —Ñ—Y“ñ˜Y. ƒXƒvƒ‰ƒCƒVƒ“ƒO‘jŠQÜRQN-18690A (18-deoxyherboxidiene)‚Ì‘S‡¬. ‘æ58‰ñ“V‘R—L‹@‰»‡•š“¢˜_‰ï. å‘ä, 9ŒŽ, 2016.
19) •Ÿ‰ªŒ[‘Ÿ, Â–؁@–L, •ž•”@–Ÿ, Š|’JGº. ’Eƒ†ƒrƒLƒ`ƒ“‰»y‘fUSP47‚̃|ƒŠƒ†ƒrƒLƒ`ƒ“œÁ‰»‚ÉŠÖ‚í‚镪Žq“à—̈æ‚Ì“¯’è. ‘æ89‰ñ“ú–{¶‰»Šw‰ï‘å‰ï. å‘ä, 9ŒŽ, 2016.
18) ã—ɉî, ¬—Ñ–œ—SŽq, •ž•”@–Ÿ, Š|’JGº. ’Eƒ†ƒrƒLƒ`ƒ“‰»y‘f‘jŠQ‚É‚æ‚éHIF-1”­Œ»ƒŒƒxƒ‹‚̐§Œä. ‘æ89‰ñ“ú–{¶‰»Šw‰ï‘å‰ï. å‘ä, 9ŒŽ, 2016.
17) Îì•¶—mAŠ}ˆäº‘ŸA¡–ì@ãāAŠ|’JGº. ”ñƒŠƒ{ƒ\[ƒ€«ƒyƒvƒ`ƒh‡¬y‘f‚Ì–Ô—…“I‹@”\‰ðÍ‹Zp‚ÌŠJ”­. ‘æ10‰ñƒoƒCƒIŠÖ˜A‰»ŠwƒVƒ“ƒ|ƒWƒEƒ€. Îì, 9ŒŽ, 2016.
16) Š|’JGº. uV‚µ‚¢R^‹Û–òƒV[ƒhŠJ”­‚Æ“K‰žŠg‘åí—ªv\R^‹Û–òŠJ”­‚Ì‚œ‚߂̃Pƒ~ƒJƒ‹ƒoƒCƒIƒƒW[Œ€‹†•û—ªFƒV[ƒh•ªŽqŠJ”­‚ƃƒJƒjƒYƒ€‰ðÍ. ‹Zpî•ñ‹Š‰ïƒZƒ~ƒi[. “Œ‹ž, 8ŒŽ, 2016.iµ‘ҍu‰‰j
15) Kakeya, H. Development of new anticancer drugs targeting TGF-ƒÀ and HIF signaling pathway. 2016 BIO International Convention. San Francisco, CA, USA, Jun. 2016.
14) Š|’JGº. ‘n–òƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[F¶‘Ì“à”÷¬ŠÂ‹«ƒVƒOƒiƒ‹‚̐§Œä. V‹K‘fÞ’TõŒ€‹†‰ïE‘æ15‰ñƒZƒ~ƒi[. ‰¡•l, 6ŒŽ, 2016. iµ‘ҍu‰‰j
13) ’‡’J’G, ™ŽR—Ž‰î, Œ‘ºTˆê, Š|’JGº. ¶‘Ì–Œ‚Æ‘ŠŒÝì—p‚·‚é5aTHQ—ނ̍\‘¢Šˆ«‘ŠŠÖŒ€‹†‚ÆŒuŒõƒvƒ[ƒuŠJ”­. “ú–{ƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[Šw‰ï ‘æ11‰ñ”N‰ï. ‹ž“s, 6ŒŽ, 2016.
12) ¬“ˆ‘ˆê, Š|’JGº, ŒÃ’J —T, ‘Šè‰pŽ÷, Œ‰Y˜a’m. ŽŸ¢‘㐶–œŠî”Õ‹Zp‚ð—p‚¢‚œBŒ^ŠÌ‰Š§ˆ³‚Ì‚œ‚ß‚Ì‘n–òŒ€‹†. ‘æ26‰ñRƒEƒBƒ‹ƒX—Ö@Šw‰ï‘‰ï. ˆ€’m, 5ŒŽ, 2016.
11) ¬“ˆ‘ˆê, ŒÃ’J —T, Š|’JGº. ƒVƒ“ƒ|ƒWƒEƒ€EBŒ^ŠÌ‰ŠŒ€‹†‚ÌUp-To-DateFƒCƒ“ƒ^[ƒtƒFƒƒ“—lŠˆ«‚ðŽ‚Â’á•ªŽq‰»‡•šCDM‚É‚æ‚écccDNA—}§ì—p‚̉ðÍ. ‘æ52‰ñ“ú–{ŠÌ‘ŸŠw‰ï‘‰ï. ç—t, 5ŒŽ, 2016.
10) Š|’JGº. TGF-ƒÀ‚š‚æ‚Ñ’áŽ_‘f‰ž“šƒVƒOƒiƒ‹‚ð•W“I‚Æ‚µ‚œV‹K‚ª‚ñŽ¡—Öò‚ÌŠJ”­Œ€‹†. ‘æ15‰ñ‘ÛƒoƒCƒIƒeƒNƒmƒƒW[“WŽŠ‰ïiBIOtech 2016j. “Œ‹ž, 5ŒŽ, 2016.
9) Kakeya, H. Microbial metabolites-prompted chemical biology: Phenotypic screening and a new platform for target identification. The Fifth Symposium of RIKEN-Max Planck Joint Research Center for System Chemical Biology. Berlin, Germany, Apr. 2016. iµ‘ҍu‰‰j
8) ‚‹ŽL–Ÿ, —с@G–Ÿ, Š|’JGº. ’áŽ_‘f—U“±ˆöŽqiHIFj‘jŠQŠˆ«‚ð—L‚·‚éŠÂóƒfƒvƒVƒyƒvƒ`ƒhverucopeptin‚Ì‘S‡¬Œ€‹†. “ú–{–òŠw‰ï‘æ136”N‰ï. ‰¡•l, 3ŒŽ, 2016.
7) ™ŽR—Ž‰î, Œ‘ºTˆê, ”öè‘Ÿ˜Y, ó…r•œ, ”ö’‡GN, Š|’JGº. ‘åŠw‰@¶ƒVƒ“ƒ|ƒWƒEƒ€FŽ‰Ž¿Œ‹‡«“V‘R•š‚ÌŠˆ—p\•úü‹Û•¡‡”|—{‰t‚æ‚茩o‚µ‚œV‹KƒAƒ‹ƒJƒƒCƒhŒQ‚ÉŠÖ‚·‚錀‹†. “ú–{–òŠw‰ï‘æ136”N‰ï. ‰¡•l, 3ŒŽ, 2016. iµ‘ҍu‰‰j
6) Cornelio, K., Matsumori, N., Murata, M., Nishimura, S., Kakeya, H., Yoshida, M., Matsunaga, S. Examination of apossible mechanism for the membrane translocation of the marine sponge-derived bioactive metabolite TNM-A. “ú–{‰»Šw‰ï96t‹G”N‰ïi2016j, ‹ž“s, 3ŒŽ, 2016.
5) ‰º‘º“ml, ”öè‘Ÿ˜Y, ™ŽR—Ž‰î, Œ‘ºTˆê, ó…r•œ, Š|’JGº, ”ö’‡GN. •¡‡”|—{“ÁˆÙ“I‚ɐ¶ŽY‚³‚ê‚éƒeƒgƒ‰ƒqƒhƒƒLƒmƒŠƒ“¶‡¬ˆâ“`Žq‚̉ðÍ. “ú–{”_Œ|‰»Šw‰ï2016”N“x‘å‰ï. ŽD–y, 3ŒŽ, 2016.
4) Nishimura, S., Ito, A., Kakeya, H. Strict recognition of membrane lipids by a sea cucumber saponin, holotoxin B. Gordon Research Conference-Marine Natural Products-, Ventra, CA, USA, Mar., 2016.
3) ‹g‘º@Ê, Œ‘ºTˆê, ‘å’ˍ¹D, •ž•”@–Ÿ, Š|’JGº. E’áŽ_‘f—U“±ˆöŽq(HIF)‘jŠQŠˆ«‚ð—L‚·‚éverucopeptin‚̍\‘¢‰ðÍ‚ƍì—p‹@˜‰ðÍ, VŠwp—̈挀‹†u“V‘R•šƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[F•ªŽq•W“I‚ÆŠˆ«§Œäv’n‹æƒ~ƒjƒVƒ“ƒ|ƒWƒEƒ€i‹ž“sj, ‹ž“s, 2ŒŽ, 2016.
2) Kakeya, H. Academic drug discovery research: Phenotypic screening and target identification. University of Bordeaux-Kyoto University Mini-Symposium on Biomolecular Science. Kyoto, Jan. 2016. iµ‘ҍu‰‰j
1) Nishimura, S., Moriyama, A., Katagiri, N., Takahashi, N., Kakeya, H. In vivo linking of membrane lipids and membrane proteins using amphiphilic lipid probes. The 8th Takeda Science Foundation Symposium on PharmaSciences: Biomolecule-Based Medicinal Science: Featuring Mid-Size Drugs. Osaka, Jan. 2016.

2015

31) Kakeya, H. Natural products-based academic drug discovery. International symposium on natural products chemistry and chemical biology 2015. Hawaii, USA, Dec., 2015. iµ‘ҍu‰‰j
30) Kakeya, H. Natural products-prompted chemical biology; Phenotypic screening and target identification. The International Chemical Congress of Pacific Basin Societies 2015 (PACIFICHEM 2015). Hawaii, USA, Dec., 2015. iµ‘ҍu‰‰j
29) Lu, S., Nishimura, S., Hirai, G., Ito, M., Kawahara, T., Izumikawa, M., Sodeoka, M., Shin-ya, K., Tsuchida, T., Kakeya, H. Saccharothliolides A-C, novel phenyl-substituted 10-membered macrolides from a rare actinomycete Saccharothrix sp., identified by HPLC-MS profiling of microbial metabolites. The International Chemical Congress of Pacific Basin Societies 2015 (PACIFICHEM 2015). Hawaii, USA, Dec., 2015.
28) Takahashi, N., Hayashi, H., Kakeya, H. Synthetic study on the antitumor cyclodepcipeptide metabolite, verucopeptin. The International Chemical Congress of Pacific Basin Societies 2015 (PACIFICHEM 2015). Hawaii, USA, Dec., 2015.
27) Sugiyama, R., Nishimura, S., Ozaki, T., Asamizu, S., Onaka, H., Kakeya, H. 5-Alkyl-1,2,3,4-tetrahydroquinolines (5aTHQs), new membrane-interacting lipophilic metabolites, produced by combined-culture of Streptomyces nigrescens and Tsukamurella pulmonis. The International Chemical Congress of Pacific Basin Societies 2015 (PACIFICHEM 2015). Hawaii, USA, Dec., 2015.
26) Nishimura, S., Sugiyama, R., Fujita, K., Ito, S., Sakanishi, K., Iwabuchi, Y., Kanoh, N., Matsumori, N., Kakeya, H. Structure and function of heronamides, polyene macrolactams from marine-derived actinomycetes . The International Chemical Congress of Pacific Basin Societies 2015 (PACIFICHEM 2015). Hawaii, USA, Dec., 2015.
25) Ishikawa, F., Miyamoto, K., Konno, S., Kasai, S., Kakeya, H. Accurate detection and manipulation of adenylation domain functions in nonribosomal peptide synthetases by an enzyme-linked immunosorbent assay system using active site-directed probes for adenylation domains. The International Chemical Congress of Pacific Basin Societies 2015 (PACIFICHEM 2015). Hawaii, USA, Dec., 2015.
24) Konno, S., Ishikawa, F., Suzuki, T., Dohmae, N., Kakeya, H. Profiling of nonribosomal peptide synthetase activities using active site-directed proteomic probes for adenylation domains. The International Chemical Congress of Pacific Basin Societies 2015 (PACIFICHEM 2015). Hawaii, USA, Dec., 2015.
23) Nishimura, S., Kakeya, H. Sterol-targeting antibiotics and the balance of membrane trafficking. The International Chemical Congress of Pacific Basin Societies 2015 (PACIFICHEM 2015). Hawaii, USA, Dec., 2015.
22) Yoshimura, A., Nishimura, S., Otsuka, S., Hattori, A., Kakeya, H. Studies on the microbial metabolite verucopeptin, an inhibitor of HIF-signaling pathway. SKO Symposium 2015 (Joint Symposium 2015 of Seuol Univ., Kyoto Univ., and Osaka Univ.), Seoul, Nov., 2015.
21) Š}ˆäº‘Ÿ, Îì•¶—m, Š|’JGº. ”ñƒŠƒ{ƒ\[ƒ€«ƒyƒvƒ`ƒh‡¬y‘f‚Ì–|–óŒãCü‚ð•W“I‚Æ‚µ‚œ‰»Šwƒvƒ[ƒu‚ÌŠJ”­. ‘æ65‰ñ“ú–{–òŠw‰ï‹ß‹EŽx•”‘‰ïE‘å‰ï. 10ŒŽ, ‘åã, 2015.
20) Îì•¶—m, ¡–ìãÄ, Š}ˆäº‘Ÿ, —é–ØŒ’—T, “°‘O’Œ, Š|’JGº. ‡¬¬•ªŽq‰»‡•šŒQ‚É‚æ‚éƒAƒfƒjƒŒ[ƒVƒ‡ƒ“ƒhƒƒCƒ“‚Ì‘I‘ð“I•WŽ¯‰»‚š‚æ‚уvƒƒtƒ@ƒCƒŠƒ“ƒO‚Ö‚Ì“WŠJ. ‘æ9‰ñƒoƒCƒIŠÖ˜A‰»ŠwƒVƒ“ƒ|ƒWƒEƒ€. 9ŒŽ, ŒF–{, 2015.iu‰‰Ü‚ðŽóÜj
19) Š’ŒŽ÷, ˆÉ“ŒrÆ, Ž›“ˆ—D‘Ÿ, âŒq•œ, ŠâŸºDŽ¡, “¡“cq•œ, ™ŽR—Ž‰î, Œ‘ºTˆê, Š|’JGº. Heronamides A-C ‚Ì‘S‡¬‚ƍ\‘¢‰ü’ùA‚š‚æ‚э\‘¢Šˆ«‘ŠŠÖ. ‘æ57‰ñ“V‘R—L‹@‰»‡•š“¢˜_‰ï. ‰¡•l, 9ŒŽ, 2015.
18) Lu, S., Nishimura, S., Hirai, G., Ito, M., Kawahara, T., Izumikawa, M., Sodeoka, M., Shin-ya, K., Tsuchida, T., Kakeya, H. Studies on Saccharothriolides A-C, Novel Phenyl-substituted 10-Membered Macrolidesfrom a Rare Actinomycete Saccharothrix sp. 57th Symposium on the chemistry of natural products. Yokohama, Sep. 2015.
17) Žl•û“c—I•ã, “¡“cq•œ, ûPŒËŠG—¢, Œ‘ºTˆê, •œ‰ª^Š°, ŒŽ“c_, Š|’JGº. IDH3ƒ¿\HIF-1Œo˜H‚𐧌䂷‚鐶•šŠˆ«•šŽ¿‚Ì’TõŒ€‹†. ‘æ26‰ñV–ò‘n»’k˜b‰ï. Ã‰ª, 9ŒŽ, 2015. (—DG”­•\Üi§—ãÜj‚ðŽóÜ)
16) Š|’JGº. ‰¿’l‘n‘¢Œ^‘n–òƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[, ‘æ7‰ñ–òŠw‚Ì–¢—ˆ‚ðl‚Š‚é‹ž“sƒVƒ“ƒ|ƒWƒEƒ€u–òEHEˆã˜AŒg‚É‚æ‚鉿’l‘n‘¢Œ^‘n–òŒ€‹†‚̃tƒƒ“ƒeƒBƒAv, ‹ž“s, 8ŒŽ, 2015.
15) Š|’JGº. ‹ž“s‘åŠwƒI[ƒvƒ“ƒLƒƒƒ“ƒpƒXE–òŠw•”E–Í‹[Žö‹Æ. ‘n–òEˆç–ò‚Ö‚Ì’§íFŽ©‘R‚ÉŠw‚ÔƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[Œ€‹†. ‹ž“s, 8ŒŽ, 2015.
14) Š|’JGº. ƒVƒ“ƒ|ƒWƒEƒ€u‘n–ò‚̏«—ˆv. ‘n–òƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[FƒV[ƒh•ªŽqŠJ”­‚Æ•ªŽqƒvƒƒtƒ@ƒCƒŠƒ“ƒO. ‘æ63‰ñ“ú–{‰»Šw—Ö@Šw‰ï‘‰ï. “Œ‹ž, 6ŒŽ, 2015. iµ‘ҍu‰‰j
13) ¡–ìãÄ, Îì•¶—m, —é–ØŒ’—T, “°‘O ’Œ, Š|’JGº. ƒAƒfƒjƒŒ[ƒVƒ‡ƒ“ƒhƒƒCƒ“‚ɑ΂·‚銈«•”ˆÊŽwŒüŒ^ƒvƒ[ƒu‚ð—p‚¢‚œ”ñƒŠƒ{ƒ\[ƒ€«ƒyƒvƒ`ƒh‡¬y‘fŠˆ«‚̃vƒƒtƒ@ƒCƒŠƒ“ƒO. ‘æ15‰ñ“ú–{’`”’Ž¿‰ÈŠw‰ï”N‰ï, “¿“‡, 6ŒŽ, 2015.
12) Nishimura, S., Sugiyama, R., Fujita, K., Kakeya, H. Abnormal cell wall deposition by heronamides, small molecules targeting phospholipids possessing saturated hydrocarbon chain. Pombe 2105 (8th International Fission Yeast Meeting), Kobe, Japan, June, 2015.
11) Š}ˆäº‘Ÿ, Îì•¶—m, Š|’JGº. ”ñƒŠƒ{ƒ\[ƒ€«ƒyƒvƒ`ƒh‡¬y‘f‚Ì’S‘̃^ƒ“ƒpƒNŽ¿‚ð•W“I‚Æ‚µ‚œ’ᕪŽqƒvƒ[ƒu‚ÌŠJ”­. “ú–{ƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[Šw‰ïE‘æ10‰ñ”N‰ï, å‘ä, 6ŒŽ, 2015.
10) ¡–ìãÄ, Îì•¶—m, —é–ØŒ’—T, “°‘O’Œ, Š|’JGº. ƒAƒfƒjƒŒ[ƒVƒ‡ƒ“ƒhƒƒCƒ“‚ɑ΂·‚銈«•”ˆÊŽwŒüŒ^ƒvƒ[ƒu‚ð—˜—p‚µ‚œ”ñƒŠƒ{ƒ\[ƒ€«ƒyƒvƒ`ƒh‡¬y‘fŠˆ«‚̃vƒƒtƒ@ƒCƒŠƒ“ƒO. “ú–{ƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[Šw‰ïE‘æ10‰ñ”N‰ï, å‘ä, 6ŒŽ, 2015.[—DGƒ|ƒXƒ^[Ü‚ðŽóÜ]
9) Š|’JGº. ¶‘Ì“à”÷¬ŠÂ‹«ƒVƒOƒiƒ‹‚ð•W“I‚Æ‚µ‚œ‘n–òƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[. ‘n–ò–ò—ƒtƒH[ƒ‰ƒ€E‘æ58‰ñ’k˜b‰ï. “Œ‹ž, 5ŒŽ, 2015. iµ‘ҍu‰‰j
8) Š|’JGº. ’†’·Šúƒe[ƒ}ƒVƒ“ƒ|ƒWƒEƒ€i“ú–{‰»Šw‰ïEƒCƒuƒjƒ“ƒOƒZƒbƒVƒ‡ƒ“ju¶‡¬ƒ}ƒVƒiƒŠ[‚Æ“V‘R•šƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[‚Ì—Z‡‚É‚æ‚éV“WŠJv. æ“±“I“V‘R•šƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[F•\Œ»Œ^ƒXƒNƒŠ[ƒjƒ“ƒO‚Æ•W“I’TõE“¯’è. “ú–{‰»Šw‰ï‘æ95t‹G”N‰ï. ç—t, 3ŒŽ, 2015. iµ‘ҍu‰‰j
7) Kakeya, H. Technologies bridging metabolome and clock -Chemical biology for drug discovery; seed molecules development and target identification-. International Symposium on RNA and Clock: Epigenetic Landscape in Biological Rhythms. Hyogo, Mar. 2015. iµ‘ҍu‰‰j
6) “¡“cq•œ, ™ŽR—Ž‰î, Œ‘ºTˆê, Š|’JGº. Heronamide A‚š‚æ‚ÑB‚̐¶¬‹@\‚ÉŠÖ‚·‚錀‹†. “ú–{–òŠw‰ï‘æ135”N‰ïi_ŒËj. _ŒË, 3ŒŽ, 2015.
5) ¡–ìãāAÎì•¶—mA—é–ØŒ’—TA“°‘O’ŒAŠ|’JGº. ƒAƒfƒjƒŒ[ƒVƒ‡ƒ“ƒhƒƒCƒ“‚ɑ΂·‚銈«•”ˆÊŽwŒüŒ^ƒvƒ[ƒu‚ÌŠJ”­. “ú–{–òŠw‰ï‘æ135”N‰ïi_ŒËj. _ŒË, 3ŒŽ, 2015. [—DG”­•\Ü‚ðŽóÜ]
4) Š}ˆäº‘Ÿ, Îì•¶—m, Š|’JGº, ”ñƒŠƒ{ƒ\[ƒ€«ƒyƒvƒ`ƒh‡¬y‘f‚̂؃vƒ`ƒWƒ‹’S‘̃^ƒ“ƒpƒNŽ¿‚ð•W“I‚Æ‚µ‚œƒvƒ[ƒu‚ÌŠJ”­Œ€‹†. “ú–{–òŠw‰ï‘æ135”N‰ïi_ŒËj. _ŒË, 3ŒŽ, 2015.
3) Îì•¶—m, ¡–ìãÄ, Š|’JGº. Šˆ«•”ˆÊŽwŒüŒ^ƒvƒ[ƒu‚̓AƒfƒjƒŒ[ƒVƒ‡ƒ“ƒhƒƒCƒ“‚ð‚‘I‘ð“I‚É•WŽ¯‚·‚é. ‘æ17‰ñ¶–œ‰»ŠwŒ€‹†‰ï, ‚’m, 1ŒŽ, 2015.
2) Sugiyama, R., Nishimura, S., Ozaki, T., Onaka, H., Kakeya, H. 5-Alkyl-1,2,3,4-tetrahydroquinolines, membrane-interacting lipophilic metabolites, found in a unique combined culture of Streptomyces sp. and Tsukamurella pulmonis. Natural Products 2015; Natural product discovery & development in the post genomic era [Organized by Society for Industrial Microbiology and Biotechnology (SIMB)], San Diego, CA, USA, Jan. 2015.
1) Kakeya, H., Yoshimura, A., Sugiyama, R., Kishimoto, S., Nishimura, S., Hattori, A., Ishikawa, F., Yomoda, Y., Lu, S., Katagiri, N., Shimada, S., Seto, E., Hayashi, H., Takahashi, N., Harada, H. Chemical Biology for modulators targeting cancer microenvironment and cell membrane signaling. Natural Products 2015; Natural product discovery & development in the post genomic era [Organized by Society for Industrial Microbiology and Biotechnology (SIMB)] , San Diego, CA, USA, Jan. 2015.

2014


32) Š|’JGº. ƒVƒ“ƒ|ƒWƒEƒ€Eƒ‚ƒmƒgƒŠ‚̐V“WŠJF ‘n–òƒV[ƒYŠJ”­‚ðŽwŒü‚µ‚œ“V‘R•šƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[ -•\Œ»Œ^ƒXƒNƒŠ[ƒjƒ“ƒO‚Æ•W“I’TõE“¯’è-. ‘æ20‰ñ“V‘R–ò•š‚ÌŠJ”­‚Ɖž—pƒVƒ“ƒ|ƒWƒEƒ€. “Œ‹ž, 11ŒŽ, 2014.iµ‘ҍu‰‰j
31) Îì•¶—m, ¡–ìãÄ, Š|’JGº. ƒAƒfƒjƒŒ[ƒVƒ‡ƒ“ƒhƒƒCƒ“‚ɑ΂·‚éƒe[ƒ‰[ƒƒCƒhƒPƒ~ƒJƒ‹ƒ‰ƒxƒŠƒ“ƒO–@‚ÌŠJ”­. ‘æ20‰ñ“V‘R–ò•š‚ÌŠJ”­‚Ɖž—pƒVƒ“ƒ|ƒWƒEƒ€. “Œ‹ž, 11ŒŽ, 2014.
30) Nishimura, S., Sugiyama, R., Matsumori, N., Kakeya, H. Marine natural products targeting cell membrane. 3rd Annual Conference of the International Chemical Biology Society (ICBS2014), San Francisco, CA, USA, Nov. 2014.
29) ŠÝ–{^Ž¡, Œ‘ºTˆê, •ž•”–Ÿ, ”g‘œ–ì˜aŽ÷, ŒÜ\—’‰ë”V, Š|’JGº. ƒAƒVƒ‹ƒOƒAƒjƒWƒ“\‘¢‚ð—L‚·‚éV‹KƒVƒfƒƒtƒHƒAchlorocatechelin—Þ‚Ì’P—£E\‘¢Œˆ’èA‘S‡¬A‚š‚æ‚ѐ¶•šŠˆ«. ‘æ56‰ñ“V‘R—L‹@‰»‡•š“¢˜_‰ï. ‚’m, 10ŒŽ, 2014.
28) ¡–ìãÄ, Îì•¶—m, Š|’JGº. Šˆ«•”ˆÊŽwŒüŒ^ƒvƒ[ƒu‚ð—p‚¢‚œƒAƒfƒjƒŒ[ƒVƒ‡ƒ“ƒhƒƒCƒ“‚Ì‘I‘ð“I•WŽ¯‰». ‘æ8‰ñƒoƒCƒIŠÖ˜A‰»ŠwƒVƒ“ƒ|ƒWƒEƒ€. 9ŒŽ, ‰ªŽR, 2014.
27) Îì •¶—m, ‹{–{ Œ’Œá, ¡–ì ãÄ, Š}ˆä º‘Ÿ, Š|’J Gº. i‰»•ªŽqHŠw‚ðŽwŒü‚µ‚œƒAƒfƒjƒŒ[ƒVƒ‡ƒ“ƒhƒƒCƒ“‚ɑ΂·‚éELISA–@‚ÌŠJ”­. ‘æ8‰ñƒoƒCƒIŠÖ˜A‰»ŠwƒVƒ“ƒ|ƒWƒEƒ€. 9ŒŽ, ‰ªŽR, 2014.
26) “¿‘q«l, Œ‘ºTˆê, ‰z’qƒŽq, ‹g“c–«, Š|’JGº. –Œ—A‘—‚É‚æ‚é×–E–ŒƒXƒeƒ[ƒ‹ƒŠƒbƒ`ƒhƒƒCƒ“‚̋Ǎݐ§Œä‹@\‚̉ð–Ÿ. y•êˆâ“`Šw‘æ47‰ñŒ€‹†•ñ‰ï. “Œ‹ž, 9ŒŽ, 2014.
25) Kakeya, H. Chemical biology for drug discovery and target identification. IUPAC2014 & 248th ACS (American Chemical Society) National Meeting, San Francisco, CA, USA, Aug. 2014. (µ‘ҍu‰‰)
24) Â–Ø–L, –p‹Ñ‰Ô, ¬—Ñ–œ—SŽq, •ž•”–Ÿ, Š|’JGº.@’Eƒ†ƒrƒLƒ`ƒ“‰»y‘fUSP47‚ÌŠˆ«”­Œ»‚É‚š‚¯‚éC––’[—̈æ‚Ì–ðŠ„. ‘æ19‰ñ“ú–{•a‘ÔƒvƒƒeƒA[ƒ[Šw‰ïŠwpW‰ï. ‘åã, 8ŒŽ, 2014.
23) Š|’JGº. ‹ž“s‘åŠwƒI[ƒvƒ“ƒLƒƒƒ“ƒpƒXE–òŠw•”E–Í‹[Žö‹Æ. ‘n–òEˆç–ò‚É’§‚ÞƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[. ‹ž“s, 8ŒŽ, 2014.
22) XŽR²”Ž, Œ‘ºTˆê, Š|’JGº. ¶‘Ì–Œ‚ð•W“I‚Æ‚·‚é“V‘R•š‚̍ì—p‹@˜‰ðÍ‚ðŽwŒü‚µ‚œLiDEL–@‚ÌŠJ”­. “ú–{ƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[Šw‰ïE‘æ9‰ñ”N‰ï. ‘åã, 6ŒŽ, 2014.[—DGƒ|ƒXƒ^[Ü‚ðŽóÜ]
21) ”öè‘Ÿ˜Y, ™ŽR—Ž‰î, Œ‘ºTˆê, ó…r•œ, Š|’JGº, ”ö’‡GN. •¡‡”|—{‚ð—˜—p‚µ‚œV‹Kƒeƒgƒ‰ƒqƒhƒƒLƒmƒŠƒ“—Þ‚Ì’P—£‚Æ‚»‚̐¶‡¬‚ÉŠÖ‚·‚錀‹†. 2014”N“xi‘æ29‰ñj“ú–{•úü‹ÛŠw‰ï. ˆïé, 6ŒŽ, 2014.
20) Konno, S., Ishikawa, S., Kakeya, H. Chemical labeling of adenylation domains in nonribosomal peptide synthetase. Gordon Research Conferences: Bioorganic Chemistry-Global Challenges in the 21st Century-. Andover, NH, USA, June, 2014.
19) Ishikawa, F., Konno, S., Kakeya, H Highly selective detection method for nonribosomal peptide synthetase using cocktails of active-site probes for adenylation domains. Gordon Research Conferences: Bioorganic Chemistry-Global Challenges in the 21st Century-. Andover, NH, USA, June, 2014.
18) Š|’JGº. ‘n–òƒV[ƒYŠJ”­‚ðŽwŒü‚µ‚œ“V‘R•šƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[. “V‘R•šƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[ -•ªŽq•W“I‚ÆŠˆ«§Œä-E‘æ6‰ñŒöŠJƒVƒ“ƒ|ƒWƒEƒ€. ˆ€’m, 5ŒŽ, 2014.iµ‘ҍu‰‰j
17) ŠÝ–{^Ž¡, Œ‘ºTˆê, •ž•”–Ÿ, ”g‘œ–ì˜aŽ÷, ŒÜ\—’‰ë”V, Š|’JGº. V‹KƒVƒfƒƒtƒHƒAchlorocatechelin—Þ‚Ì’P—£E\‘¢Œˆ’è‚Æ“SŒ‹‡”\•]‰¿. •¶‰ÈÈu‰»Šw—Ö@Šî”ÕŽx‰‡Šˆ“®v ‘æ3‰ñƒVƒ“ƒ|ƒWƒEƒ€uƒAƒJƒfƒ~ƒA‚©‚ç‚̍R‚ª‚ñÜ‘n–ò‚ÉŒü‚¯‚āv. ‰«“ê, 5ŒŽ, 2014
16) “ˆ“cŽ, ‹g‘ºÊ, ˆÀ“c‡M, ‚‹ŽL–Ÿ, Œ‘ºTˆê, •ž•”–Ÿ, Š|’JGº. ‚ª‚ñ•ªŽq•W“I‘n–ò‚ðŽwŒü‚µ‚œ’áŽ_‘f—U“±ˆöŽq(HIF)‘jŠQÜ‚Ì’TõEŠJ”­Œ€‹†. •¶‰ÈÈu‰»Šw—Ö@Šî”ÕŽx‰‡Šˆ“®v ‘æ3‰ñƒVƒ“ƒ|ƒWƒEƒ€uƒAƒJƒfƒ~ƒA‚©‚ç‚̍R‚ª‚ñÜ‘n–ò‚ÉŒü‚¯‚āv. ‰«“ê, 5ŒŽ, 2014.
15) Š|’JGº. ƒVƒ“ƒ|ƒWƒEƒ€E“V‘R•šƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[(2)FƒPƒ€EƒoƒCƒIƒPƒ~ƒXƒgƒŠ[F”÷¶•š‹@”\‚ðŠˆ—p‚µ‚œ‘n–òƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[Œ€‹†. “ú–{–òŠw‰ï134”N‰ï. ŒF–{, 3ŒŽ, 2014.iµ‘ҍu‰‰j
14) ŠÝ–{^Ž¡, Œ‘ºTˆê, •ž•”–Ÿ, ”g‘œ–ì˜aŽ÷, ŒÜ\—’‰ë”V, Š|’JGº. Streptomyces‘®•úü‹Û‚æ‚茩o‚µ‚œ‰–‘fŒŽŽqŠÜ—LV‹KƒVƒfƒƒtƒHƒA‚Ì’P—£E\‘¢Œˆ’è. “ú–{–òŠw‰ï134”N‰ï. ŒF–{, 3ŒŽ, 2014. [—DG”­•\Ü‚ðŽóÜ], [”N‰ï”­•\ƒnƒCƒ‰ƒCƒg‚ɍ̑ð]
13) ™ŽR—Ž‰î, Œ‘ºTˆê, ”öè‘Ÿ˜Y, ”ö’‡GN, Š|’JGº. ƒeƒgƒ‰ƒqƒhƒƒLƒmƒŠƒ“œŠi‚ð—L‚·‚éV‹K•úü‹Û‘ãŽÓ•š‚̍\‘¢‘œ—l«‚Ɛ¶•šŠˆ«. “ú–{–òŠw‰ï134”N‰ï. ŒF–{, 3ŒŽ, 2014. [—DG”­•\Ü‚ðŽóÜ]
12) ‹g‘ºÊ, Œ‘ºTˆê, ‘å’ˎѐD, •ž•”–Ÿ, Š|’JGº. ’áŽ_‘f—U“±ˆöŽq(HIF)Šˆ«‰»Œo˜H‚ð‘jŠQ‚·‚éverucopeptin‚̍ì—p‹@˜‰ðÍ. “ú–{–òŠw‰ï134”N‰ï. ŒF–{, 3ŒŽ, 2014.
11) ˆÀ“c‡M, “ê“c—L”ü, rì•–Ÿ, “ˆ“cŽ, •ž•”–Ÿ, Œ‘ºTˆê, ‘åÎ^–ç, “¡ˆäMF, Š|’JGº. V‹K’áŽ_‘f—U“±ˆöŽqHIF‘jŠQÜ‚Ì’Tõ‚ƍ\‘¢Šˆ«‘ŠŠÖŒ€‹†. “ú–{–òŠw‰ï134”N‰ï. ŒF–{, 3ŒŽ, 2014.
10) ‚‹ŽL–Ÿ, Š|’JGº. RŽîᇐ«ŠÂóƒfƒvƒVƒyƒvƒ`ƒhverucopeptin‚Ì‘S‡¬Œ€‹†. “ú–{–òŠw‰ï134”N‰ï. ŒF–{, 3ŒŽ, 2014.
9) ¡–ìãÄ, Îì•¶—m, Š|’JGº. Œõe˜a«ƒvƒ[ƒu‚ð—˜—p‚µ‚œƒAƒfƒjƒŒ[ƒVƒ‡ƒ“ƒhƒƒCƒ“‚ɑ΂·‚郊ƒKƒ“ƒhˆË‘¶“I•WŽ¯‰». “ú–{–òŠw‰ï134”N‰ï. ŒF–{, 3ŒŽ, 2014
8) Žë–ì–Ÿ•F, Œ‘ºTˆê, ‰Á“¡•œ, Š|’JGº. Chaetoglobosin D‚ÍROSŽY¶‚É‚æ‚è×–E‚̃ZƒŠƒ“Ž‘‰»‚ð‘jŠQ‚·‚é. “ú–{–òŠw‰ï134”N‰ï. ŒF–{, 3ŒŽ, 2014.
7) ¬—Ñ–œ—SŽq, •ž•”–Ÿ, Â–Ø–L, Š|’JGº. ’EUrm1‰»Šˆ«‚ÌŒŸo‚š‚æ‚Ñ•ªŽq“¯’è. “ú–{–òŠw‰ï134”N‰ï. ŒF–{, 3ŒŽ, 2014.
6) Â–؁@–L, –p@‹Ñ‰Ô, ¬—с@–œ—SŽq, •ž•”@–Ÿ, Š|’J@Gº. ’Eƒ†ƒrƒLƒ`ƒ“‰»y‘f(USP)47‚Ì•ªŽq“àƒhƒƒCƒ“‚Ì‹@”\‰ðÍ. “ú–{–òŠw‰ï134”N‰ï. ŒF–{, 3ŒŽ, 2014.
5) ‰ª‘ºMŽq, »ì—zˆê, “â‘׎j, •œ–쑁ŠG, •À–؉ër, “n糗Yˆê, “yˆäC, ‰¡’níL, ‚‹ŽŽi, Œˆä’l, à_“c—FŽq, ¡òŒú, ‹Ž–{³, Š|’JGº, ˜a“cŒ[“¹, “‡’ÏÍ, ’·’Jì_“ñ, X–{’B–ç. –³ìˆ×Š„•tƒNƒƒXƒI[ƒo[2d–ÓŒŸŽŽŒ±‚É‚æ‚Á‚ÄTheracurmin‚Í‘Œ‚̃Nƒ‹ƒNƒ~ƒ“»Ü‚æ‚è‚à—D‚ê‚œ‹zŽûŒø—Š‚ÌŒüã‚ª‚Ý‚ç‚ê‚œ. “ú–{–òŠw‰ï134”N‰ï. ŒF–{, 3ŒŽ, 2014.
4) Sugiyama, R., Nishimura, S., Matsumori, N., Tsunematsu, Y., Hattori, A., Kakeya, H. Mode of action of heronamides, polyene macrolactams from a marine-derived Streptomyces sp. Gordon Research Conferences: Marine natural products- from discovery to human health-. Ventura, CA, USA, Mar. 2014.
3) Š|’JGº. ‘n–òEˆç–ò‚É’§‚ÞƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[F–òŠw‚Ö‚Ì—Ui‚¢‚Ž‚ȁj‚¢. —Œ–kƒqƒ|ƒNƒ‰ƒeƒX‹äŠy•”, ‹ž“s•{—§—Œ–k‚“™ŠwZ. 3ŒŽ, 2014.iµ‘ҍu‰‰j
2) Yoshimura, A., Nishimura, S., Otsuka, S., Hattori, A. Kakeya, H. Mode of action of vercopeptin, an inhibitor of HIF-signaling pathway isolated from an actinomycete. The 12th International Student Seminar (12th ISS), Kyoto Univeristy. Kyoto, Feb. 2014.
1) Š|’JGº. •œ¬25”N“x‹ž“s–ò‰È‘åŠw‘æ2‰ñ‘n–ò‰ÈŠwƒtƒƒ“ƒeƒBƒAƒVƒ“ƒ|ƒWƒEƒ€. ‘n–òƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[F•\Œ»Œ^ƒXƒNƒŠ[ƒjƒ“ƒO‚Æ•W“I“¯’è. ‹ž“s, 2ŒŽ, 2014.iµ‘ҍu‰‰j

2013


21) Žë–ì–Ÿ•F, Œ‘ºTˆê, ‰Á“¡ •œ, Š|’JGº. ƒZƒŠƒ“‘ãŽÓ‚̓AƒNƒ`ƒ“‘jŠQÜ‚Ö‚ÌŠŽŽó«‚ðãž‚³‚¹‚é. ‘æ5‰ñH•i–òŠwƒVƒ“ƒ|ƒWƒEƒ€. ‹ž“s, 11ŒŽ, 2013.
20) Œ‘ºTˆê, “¿‘q«l, ‰z’qƒŽq, ‹g“c–«, Š|’JGº. ƒXƒeƒ[ƒ‹ƒŠƒbƒ`×–E–ŒƒhƒƒCƒ“‚ÌŒ`¬‹@\‚̉ðÍ. ‘æ5‰ñH•i–òŠwƒVƒ“ƒ|ƒWƒEƒ€. ‹ž“s, 11ŒŽ, 2013. [—DG”­•\Ü‚ðŽóÜ]
19) ‹{–{Œ’Œá, Îì•¶—m, —с@–L, Š|’JGº. Ž…ó‹ÛNeosartorya‘®—R—ˆƒvƒŒƒjƒ‹Šî“]ˆÚy‘f‚ÉŠÖ‚·‚錀‹†. ‘æ5‰ñH•i–òŠwƒVƒ“ƒ|ƒWƒEƒ€. 11ŒŽ, ‹ž“s, 2013.
18) Š}ˆäº‘Ÿ, Žðˆä—C‹X, PŒ—Y‘Ÿ, •ž•”–Ÿ, Œ‘ºTˆê, Š|’JGº. TGF-ƒÀƒVƒOƒiƒ‹‘jŠQŠˆ«‚ð—L‚·‚é“V‘R•šƒgƒŠƒvƒgƒyƒvƒ`ƒ“A‚Ì•W“I•ªŽq’TõŒ€‹†. ‘æ5‰ñH•i–òŠwƒVƒ“ƒ|ƒWƒEƒ€. ‹ž“s, 11ŒŽ, 2013.@[—DG”­•\Ü‚ðŽóÜ]
17) Kakeya, H. Natural Products-Initiated Chemical Biology; Screening, Discovery, and Target Identification. 13th International Conference on the Chemistry and other bioactive compounds (ICCA-13), Yamanashi, Sep. 2013. (Invited Lecture)
16) ™ŽR—Ž‰î, Œ‘ºTˆê, ŒXM–Ÿ, PŒ—Y‘Ÿ, •ž•”–Ÿ, ‘º“c“¹—Y, Š|’JGº. ŠC—m—R—ˆ•úü‹Û‚ª¶ŽY‚·‚éheronamide—Þ‚Ì’P—£‚Ɛ¶•šŠˆ«. ‘æ55‰ñ“V‘R—L‹@‰»‡•š“¢˜_‰ï. ‹ž“s, 9ŒŽ, 2013.
15) ¡–ìãÄ, Îì•¶—m, Š|’JGº. ƒAƒfƒjƒŒ[ƒVƒ‡ƒ“ƒhƒƒCƒ“‚ð•W“I‚Æ‚µ‚œŒõe˜a«ƒvƒ[ƒu‚ÌŠJ”­. ‘æ7‰ñƒoƒCƒIŠÖ˜A‰»ŠwƒVƒ“ƒ|ƒWƒEƒ€.  ˆ€’m, 9ŒŽ, 2013.
14) ™–{‘׍N, Îì•¶—m, ‹{–{Œ’Œá, ŒI“c‰ëŽj, ¡–ìãÄ, Š|’JGº. Andrimid‚̐¶‡¬y‘f‚Ì‹@”\‰ðÍ. ‘æ7‰ñƒoƒCƒIŠÖ˜A‰»ŠwƒVƒ“ƒ|ƒWƒEƒ€. ˆ€’m, 9ŒŽ, 2013.
13) Nishimura, S., Tokukura, M., Ochi, J., Yoshida, M., Kakeya, H. Sterol-rich membrane domains and the balance of membrane traffic. Pombe 2013 (7th International fission yeast meeting), June, London, UK, 2013.
12) ‹{–{Œ’Œá, Îì•¶—m, —с@–L, Š|’JGº. Ž…ó‹ÛNeosartorya sp. —R—ˆƒvƒŒƒjƒ‹Šî“]ˆÚy‘f‚Ì‹@”\‰ðÍ. “ú–{ƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[Šw‰ïE‘æ8‰ñ”N‰ï. “Œ‹ž, 6ŒŽ, 2013.
11) Îì•¶—m, Š|’JGº. AdenylationƒhƒƒCƒ“‚ð•W“I‚Æ‚µ‚œ‚e˜a«ƒvƒ[ƒu‚ÌŠJ”­. “ú–{ƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[Šw‰ïE‘æ8‰ñ”N‰ï. “Œ‹ž, 6ŒŽ, 2013.
10) Îì•¶—m, Š|’JGº. LC-MS/MS‚ð—p‚¢‚œ’ᕪŽqƒvƒ[ƒu‚ɑ΂·‚é•W“Iƒ^ƒ“ƒpƒNŽ¿‚Ì“¯’è. ‘æ13‰ñ“ú–{’`”’Ž¿‰ÈŠw‰ï. ’¹Žæ, 6ŒŽ, 2013.
9) ˆÉ“¡º”Ž, Š|’JGº, ‹g“c–«. ’ESUMO‰»y‘fSENP1‘jŠQÜ‚Ì’Tõ. ‘æ17‰ñ“ú–{‚ª‚ñ•ªŽq•W“IŽ¡—Êw‰ïEŠwpW‰ï. ‹ž“s, 6ŒŽ, 2013.
8) ‹g‘º@Ê, Œ‘ºTˆê, •ž•”–Ÿ, Š|’JGº. ’áŽ_‘f—U“±ˆöŽq(HIF)Šˆ«‰»Œo˜H‚ð‘jŠQ‚·‚é•úü‹Û—R—ˆverucopeptin‚̐â‘Η§‘Ì”z’u‚ÌŒˆ’è. ‘æ17‰ñ“ú–{‚ª‚ñ•ªŽq•W“IŽ¡—Êw‰ïEŠwpW‰ï. ‹ž“s, 6ŒŽ, 2013.
7) Žë–ì–Ÿ•F, Œ‘ºTˆê, Š|’JGº. ƒAƒ~ƒmŽ_‘ãŽÓ‚ð•Ï’²‚·‚é“V‘R‰»‡•š‚Ì’TõŒ€‹†. ‘æ17‰ñ“ú–{‚ª‚ñ•ªŽq•W“IŽ¡—Êw‰ïEŠwpW‰ï. ‹ž“s, 6ŒŽ, 2013.
6) ‹{–{Œ’Œá, Îì•¶—m, —с@–L, Š|’JGº. •ªŽq‹@”\•ÏŠ·‚ðŽwŒü‚µ‚œŽ…ó‹ÛNeosartorya sp. —R—ˆƒvƒŒƒjƒ‹Šî“]ˆÚy‘f‚Ì‹@”\‰ðÍ. “ú–{–òŠw‰ï‘æ133”N‰ï. _“ސì, 3ŒŽ, 2013.
5) Îì•¶—m, Š|’JGº. —L—p¶‡¬y‘f‚Ì“¯’èE‹@”\‰ðÍ‚ðŽwŒü‚µ‚œ‰»Šwƒc[ƒ‹‚ÌŠJ”­\AdenylationƒhƒƒCƒ“‚ð•W“I‚Æ‚µ‚œ‚e˜a«ƒvƒ[ƒu‚ÌŠJ”­\. “ú–{–òŠw‰ï‘æ133”N‰ï. _“ސì, 3ŒŽ, 2013.
4) ™ŽR—Ž‰î, Œ‘ºTˆê, PŒ—Y‘Ÿ, •ž•”–Ÿ, Š|’JGº. V‹Kƒ|ƒŠƒGƒ“ƒ}ƒNƒƒ‰ƒNƒ^ƒ€–‚Ì’P—£E\‘¢Œˆ’è‚Æ‚»‚̐¶•šŠˆ«. “ú–{–òŠw‰ï‘æ133”N‰ï. _“ސì, 3ŒŽ, 2013.
3) ‹g‘º@Ê, Œ‘ºTˆê, ŠÝ–{^Ž¡, •ž•”–Ÿ, Š|’JGº. 1,3-dimethylœó\‘¢‚Ì—§‘Ì”z’uŒˆ’è–@‚ÌŒŸØFtumescenamide C‚Æverucopeptin‚ð—á‚É. “ú–{–òŠw‰ï‘æ133”N‰ï. _“ސì, 3ŒŽ, 2013.
2) –p‹Ñ‰Ô, •ž•”–Ÿ, Â–Ø–L, ¬—Ñ–œ—SŽq, X‹g‰pŽq, Š|’JGº. ’Eƒ†ƒrƒLƒ`ƒ“‰»y‘f(USP)47‚ÌŠˆ«”­Œ»‹@\‚̉ðÍ. “ú–{–òŠw‰ï‘æ133”N‰ï. _“ސì, 3ŒŽ, 2013.
1) X–{’B–ç, »ì—zˆê, “â‘׎j, •œ–쑁ŠG, •À–؉ër, “n糗Yˆê, “yˆäC, —é–ؐŽ”ü, ŽR“à‚Ý‚ä‚«, ‰¡’níL, ‘å’ËŠì•F, à_“c—FŽq, ¡òŒú, –ì’†—SŽi, •s”j‹ª, Ž›–{‹M‘¥, Š|’JGº, ˜a“cŒ[“¹, ’·’Jì_“ñ. 4»Ü–³ìˆ×Š„•tƒNƒƒXƒI[ƒo[2d–ÓŒŸŽŽŒ±‚É‚æ‚èAƒZƒ‰ƒNƒ‹ƒ~ƒ“”z‡ˆù—¿‚̍‚‚¢‹zŽûŒø—Š‚ªŽÀØ‚³‚ê‚œ. “ú–{–òŠw‰ï‘æ133”N‰ï. _“ސì, 3ŒŽ, 2013.

2012


20) –p‹Ñ‰Ô, •ž•”–Ÿ, Â–Ø–L, ¬—Ñ–œ—SŽq, X‹g‰pŽq, Š|’JGº. ’Eƒ†ƒrƒLƒ`ƒ“‰»y‘f(USP)47‚ÌŠˆ«”­Œ»‚É‚š‚¯‚镪Žq“àƒ†ƒrƒLƒ`ƒ“—lƒhƒƒCƒ“‚Ì–ðŠ„. ‘æ85‰ñ“ú–{¶‰»Šw‰ï. 12ŒŽ, •Ÿ‰ª, 2012.
19) •ž•”–Ÿ, Œì–¢—ˆŽq, –p‹Ñ‰Ô, ¬—Ñ–œ—SŽq, X‹g‰pŽq, Š|’JGº. ’Eƒ†ƒrƒLƒ`ƒ“‰»y‘fUCH-L3‚ÍŽ_‰»ƒXƒgƒŒƒX‚Ì•W“Iƒ^ƒ“ƒpƒNŽ¿‚Å‚ ‚é. ‘æ85‰ñ“ú–{¶‰»Šw‰ï. 12ŒŽ, •Ÿ‰ª, 2012.
18) Š|’JGº. µ‘ҍu‰‰F“V‘R•š‰»Šw‚ðŠî”Õ‚Æ‚µ‚œ‘n–òƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[. ŽáŽèŒ€‹†ŽÒ‚Ì‚œ‚ß‚Ì—L‹@‰»ŠwŽD–yƒZƒ~ƒi[. 11ŒŽ, –kŠC“¹, 2012.
17) Žðˆä—C‹X, Œ‘ºTˆê, •ž•”–Ÿ, ‘Ÿ“c‘ñ–€, “y‹‰ë•v, ‰ª‘º‹Ï, Š|’JGº. 3ƒÀ-Hydroxysteroid dehydrogenase (3ƒÀ-HSD) ‘jŠQÜ‚ÌŠJ”­Œ€‹†. ‘æ30‰ñƒƒfƒBƒVƒiƒ‹ƒPƒ~ƒXƒgƒŠ[ƒVƒ“ƒ|ƒWƒEƒ€. 11ŒŽ, “Œ‹ž, 2012.
16) Kanou, A., Nishimura, S., Kakeya, H. Chemical genetics for dissecting the crosstalk between cell metabolism and cell morphology. The 1st International Symposium on Chemical Biology of Natural Products: Target ID and Regulation of Bioactivity. Kyoto, Oct., 2012.
15) ‹g‘ºÊ, ‘å’ˎѐD, Œ‘ºTˆê, •ž•”–Ÿ, Š|’JGº. ’áŽ_‘f—U“±ˆöŽq(HIF)Šˆ«‰»Œo˜H‚ð‘jŠQ‚·‚éverucopeptin‚ÉŠÖ‚·‚錀‹†. ‘æ19‰ñ“V‘R–ò•š‚ÌŠJ”­‚Ɖž—pƒVƒ“ƒ|ƒWƒEƒ€. 10ŒŽ, ‘åã, 2012.
14) ’JŒû–ƒ—¢Ž}, Žðˆä—C‹X, Œ‘ºTˆê, •ž•”–Ÿ, Š|’JGº. GBF1‘jŠQŠˆ«‚ð—L‚·‚égolgicide A ‚̍\‘¢Šˆ«‘ŠŠÖŒ€‹†. ‘æ62‰ñ“ú–{–òŠw‰ï‹ß‹EŽx•”‘‰ïE‘å‰ï, 10ŒŽ, •ºŒÉ, 2012.[—DGƒ|ƒXƒ^[”­•\Ü‚ðŽóÜ]
13) ‹g‘ºÊ, ‘å’ˎѐD, Œ‘ºTˆê, •ž•”–Ÿ, ’·“c—T”V, Š|’JGº. ’áŽ_‘f—U“±ˆöŽq(HIF)Šˆ«‰»Œo˜H‚ð‘jŠQ‚·‚éverucopeptin‚̉»Šw“I‰ðÍŒ€‹†. ‘æ54‰ñ“V‘R—L‹@‰»‡•š“¢˜_‰ï. 10ŒŽ, “Œ‹ž, 2012.
12) ŒÓ‹Åœ—, •ž•”–Ÿ, Š|’JGº. ’áŽ_‘f—U“±ˆöŽq(HIF)‘jŠQÜ’Tõ‚Ì‚œ‚߂̃nƒCƒRƒ“ƒeƒ“ƒcEƒXƒNƒŠ[ƒjƒ“ƒOŒn‚̍\’z. ‘æ16‰ñ“ú–{‚ª‚ñ•ªŽq•W“IŽ¡—Êw‰ïEŠwpW‰ï. •Ÿ‰ª, 6ŒŽ, 2012.
11) ™ŽR—Ž‰î, Œ‘ºTˆê, X—[ŠóŽq, ”ö’‡GN, Š|’JGº. •úü‹Û‚Ì•¡‡”|—{‚É‚æ‚Á‚Ä“Ÿ‚ç‚ê‚éV‹Kƒeƒgƒ‰ƒqƒhƒƒLƒmƒŠƒ“—U“±‘Ì‚ÉŠÖ‚·‚錀‹†. “ú–{ƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[Šw‰ï ‘æ7‰ñ”N‰ï. 6ŒŽ, ‹ž“s, 2012.
10) •ž•”–Ÿ, Œì–¢—ˆŽq, –p‹Ñ‰Ô, ¬—Ñ–œ—SŽq, X‹g‰pŽq, Š|’JGº. Activity-based Profilling‚É‚æ‚éŽ_‰»ƒXƒgƒŒƒXŠŽŽó«’Eƒ†ƒrƒLƒ`ƒ“‰»y‘f‚Ì“¯’è. “ú–{ƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[Šw‰ï ‘æ7‰ñ”N‰ï. 6ŒŽ, ‹ž“s, 2012.
9) Hu, X.-T., Hattori, A., Tokiwa, R., Kakeya, H. A high content screening system to develop novel HIF-1 inhibitors disrupting its heterodimeric formation. Organization for Oncology and Translational Research (OOTR) 8th Annual Meeting, Kyoto, Japan, Apr. 2012.[—DGƒ|ƒXƒ^[”­•\Ü‚ðŽóÜ]
8) Piao, J.-H., Tashiro, A., Nishikawa, M., Moriyoshi, E., Hattori, A., Kakeya, H. Enzymatic properties of recombinant human ubiquitin specific protease 47. Organization for Oncology and Translational Research (OOTR) 8th Annual Meeting, Kyoto, Japan, Apr. 2012.
7) Š}ˆäº‘Ÿ, Žðˆä—C‹X, PŒ—Y‘Ÿ, •ž•”–Ÿ, ‘åÎ^–ç, “¡ˆäMF, Œ‘ºTˆê, Š|’JGº. V‹KTGF-ƒÀƒVƒOƒiƒ‹“`’B‘jŠQÜtryptopeptin A‚š‚æ‚Ñ•ªŽqƒvƒ[ƒu‚̍‡¬Œ€‹†. “ú–{–òŠw‰ï‘æ132”N‰ï. ŽD–y, 3ŒŽ, 2012.
6) ™ŽR—Ž‰î, Œ‘ºTˆê, X—[ŠóŽq, ”ö’‡GN, Š|’JGº. •úü‹Û‚ª¶ŽY‚·‚éV‹Kƒeƒgƒ‰ƒqƒhƒƒLƒmƒŠƒ“—U“±‘Ì‚Ì’P—£E\‘¢‰ðÍ. “ú–{–òŠw‰ï‘æ132”N‰ï. ŽD–y, 3ŒŽ, 2012.
5) ŒÓ‹Åœ—, •ž•”–Ÿ, í”Õ—ç, Š|’JGº. “ñ•ªŽqŒuŒõ‘Š•âƒVƒXƒeƒ€‚ð—˜—p‚µ‚œ’áŽ_‘f—U“±ˆöŽq(HIF)‘jŠQÜŠˆ«•]‰¿Œn‚̍\’z. “ú–{–òŠw‰ï‘æ132”N‰ï. ŽD–y, 3ŒŽ, 2012.
4) Œì–¢—ˆŽq, ¬—Ñ–œ—SŽq, –p‹Ñ‰Ô, X‹g‰pŽq, •ž•”–Ÿ, Š|’JGº. ’Eƒ†ƒrƒLƒ`ƒ“‰»y‘fUCH-L3‚ÍŽ_‰»ƒXƒgƒŒƒX‰º‚Å•sŠˆ«‰»‚³‚ê‚é. “ú–{–òŠw‰ï‘æ132”N‰ï. ŽD–y, 3ŒŽ, 2012.
3) –p‹Ñ‰Ô, “c‘㈟ˆß, Œì–¢—ˆŽq, X‹g‰pŽq, •ž•”–Ÿ, Š|’JGº. ƒqƒgUSP47‚Ì’Eƒ†ƒrƒLƒ`ƒ“‰»y‘fŠˆ«‚̉ðÍ. “ú–{–òŠw‰ï‘æ132”N‰ï. ŽD–y, 3ŒŽ, 2012
2) Œ‘ºTˆê, Š|’JGº. ƒVƒ“ƒ|ƒWƒEƒ€u“V‘R•š‰»Šw‚̐V‚µ‚¢’ª—¬vF¶‘Ì–Œ‚ð‰ðÍ‚·‚鉻Šwˆâ“`Šw. “ú–{–òŠw‰ï‘æ132”N‰ï. ŽD–y, 3ŒŽ, 2012. iµ‘ҍu‰‰j
1) Š|’JGº. ƒVƒ“ƒ|ƒWƒEƒ€uH•i‹@”\Šw‚Æ–ò—ŠwFÚ“_‚Æ‘Šˆá“_‚©‚çŠw‚ÔŽŸ‚̃Aƒvƒ[ƒ`Fh‚à‚Ì‚Æ‚èhEh‚à‚̂­‚èh‚ðŠî”Õ‚Æ‚µ‚œƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[Œ€‹†. “ú–{”_Œ|‰»Šw‰ï2011”N“x‘å‰ï. ‹ž“s, 3ŒŽ, 2012. iµ‘ҍu‰‰j

2011


15) Š|’JGº. ‘n–òƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[FŽ©‘R‚ÉŠw‚ԁh–òh‚­‚è. ‰ÈŠwE‹ZpƒtƒFƒXƒ^ in ‹ž“s. ‹ž“s, 12ŒŽ, 2011.
14) Morimoto, T., Wada, H., Sunagawa, Y., Fujita, M., Kakeya, H., Sasaki, H., Imaizumi, A., Hashimoto, T., Akao, M., Osakada, G., Kambara, H., Doi, O., Shiomi, H., Kimura, T., Shimatsu, A., Hasegawa, K., Effects of highly absorptive curcumin on systolic and diastolic function in hypertensive patients with left ventricular hypertrophy. Heart failure: Pharmacologic Therapy in Advanced Preclinical and Clinical Trials. American Association Scientific Sessions 2011. Orland, FL, USA, Nov. 2011.
13) Hattori, A., Tashiro, A., Piao, J.-H., Moriyoshi, E., Kakeya, H. Characterization of enzymatic properties of recombinant human specific protease 47. 7th General Meeting of the International Proteolysis Society. San Diedo, CA, USA, Oct. 2011.
12) ŠÝ–{^Ž¡, PŒ—Y‘Ÿ, Œ‘ºTˆê, •ž•”–Ÿ, Š|’JGº. •úü‹Û‚ªŽY¶‚·‚éV‹KŠÂóƒŠƒ|ƒfƒvƒVƒyƒvƒ`ƒhpentadepsin A‚ÉŠÖ‚·‚錀‹†. ‘æ53‰ñ“V‘R—L‹@‰»‡•š“¢˜_‰ï. ‘åã. 9ŒŽ, 2011.
11) Espiritu, R.A., Matsumori, N., Murata, M., Nishimura, S., Kakeya, H., Matsunaga, S., Yoshida, M. Interaction of the marine sponge cyclic peptide theonellamide A with lipid bilayers investigated by membrane-permeabilizing activities and solid state 2H NMR. 14th Asian Chemical Congress 2011. Bangkok, Thailand, Sep. 2011.
10) ‰z’qƒŽq, Œ‘ºTˆê, Š|’JGº. •ª—ôy•ê‚É‚š‚¯‚é×–E–ŒƒXƒeƒ[ƒ‹‚̋Ǎݐ§Œä‚̉ðÍ. y•êˆâ“`ŠwƒtƒH[ƒ‰ƒ€E‘æ44‰ñŒ€‹†•ñ‰ï. •Ÿ‰ª, 9ŒŽ, 2011.
9) ‘å–ì—TŽi, •ž•”–Ÿ, ã“c³“¹, ‰eŽRi, ‹g‹M’BŠ°, Š|’JGº. ƒqƒgC7orf24‚̈â“`Žq”­Œ»‚́A“]ŽÊŠJŽn“_‹ß–T‚Ì3ƒ–Š‚ÌCCAAT”z—ñ‚ɐ§Œä‚³‚ê‚é. ‘æ84‰ñ“ú–{¶‰»Šw‰ï. ‹ž“s, 9ŒŽ, 2011.
8) •ž•”–Ÿ, –p‹Ñ‰Ô, “c‘㈟ˆß, X‹g‰pŽq, Š|’JGº. ƒOƒ‰ƒ“ƒUƒCƒ€B‚ðƒŒƒ|[ƒ^[‚É—p‚¢‚œ’Eƒ†ƒrƒLƒ`ƒ“‰»y‘fŠˆ«‘ª’è–@‚̍\’z. ‘æ84‰ñ“ú–{¶‰»Šw‰ï. ‹ž“s, 9ŒŽ, 2011.
7) ‰i–{—CŽ÷, •ž•”–Ÿ, Š|’JGº, ’|–{‰ÀŽi, ‚{Žœ, ŠÜ…ðŒ‚ł̘A‘±”œ‰ž‚ð—˜—p‚µ‚œpHˆË‘¶«V‹KDNAƒAƒ‹ƒLƒ‹‰»Ü‚̐݌v. ‘æ9‰ñŽŸ¢‘ã‚ð’S‚€—L‹@‰»ŠwƒVƒ“ƒ|ƒWƒEƒ€. “Œ‹ž, 5ŒŽ, 2011.
6) ŠÝ–{^Ž¡, PŒ—Y‘Ÿ, Œ‘ºTˆê, •ž•”–Ÿ, Š|’JGº. ”÷¶•šƒƒ^ƒ{ƒ[ƒ€‰ðÍ‚É‚æ‚茩o‚µ‚œV‹KŠÂóƒŠƒ|ƒfƒvƒVƒyƒvƒ`ƒh. “ú–{–òŠw‰ï‘æ131”N‰ï. Ã‰ª, 3ŒŽ, 2011.
5) ’†“‡œ, •ž•”–Ÿ, PŒ—Y‘Ÿ, Œ‘ºTˆê, ¯Ži–ž, —Ñ—Y“ñ˜Y, ’·“c—T”V, Š|’JGº. ŒŒŠÇV¶‘jŠQÜazaspirene‚̍ì—p‹@˜‰ðÍ‚Æ•W“Iƒ^ƒ“ƒpƒNŽ¿’Tõ. “ú–{–òŠw‰ï‘æ131”N‰ï. Ã‰ª, 3ŒŽ, 2011.
4) •ž•”–Ÿ, “c‘㈟ˆß, X‹g‰pŽq, –p‹Ñ‰Ô, Š|’JGº. ’Eƒ†ƒrƒLƒ`ƒ“‰»y‘fŠˆ«‚̐V‚µ‚¢‘ª’è–@‚ÌŠm—§. “ú–{–òŠw‰ï‘æ131”N‰ï. Ã‰ª, 3ŒŽ, 2011.
3) PŒ—Y‘Ÿ, •ž•”–Ÿ, ‘åÎ^–ç, “¡ˆäMF, Œ‘ºTˆê, Š|’JGº. •úü‹Û‚̐¶ŽY‚·‚éV‹KR‚ª‚ñÜƒŠ[ƒh‰»‡•štryptopeptin‚̉»Šw\‘¢Œˆ’è. “ú–{–òŠw‰ï‘æ131”N‰ï. Ã‰ª, 3ŒŽ, 2011.
2) Š|’JGº. “Á•ÊƒVƒ“ƒ|ƒWƒEƒ€“V‘R•š‰»Šw‚ƃPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[uV‹K¶•šŠˆ«“V‘R—L‹@•ªŽq‚ÌŠJ‘ñ‚ƃPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[Œ€‹†v. “ú–{–òŠw‰ï‘æ131”N‰ï. Ã‰ª, 3ŒŽ, 2011.iµ‘ҍu‰‰j
1) Š|’JGº. ’áŽ_‘f—U“±ˆöŽq(HIF)‚Ì‹@”\§Œä•šŽ¿‚Ì’TõE•]‰¿. ‚ª‚ñŽx‰‡Šˆ“®u‰»Šw—Ö@Šî”ÕŽx‰‡Šˆ“®v-ƒAƒJƒfƒ~ƒA‚©‚ç‚̍R‚ª‚ñÜ‘n–ò‚ÖŒü‚¯‚Ä-. ‹ž“s, 3ŒŽ, 2011.

2010


12) Tsunematsu, Y., Oishi, S., Fujii, N., Nishimura, S., Hattori, A., Kakeya, H. Tryptopeptin A, a novel TGF-beta signaling inhibitor from Streptomyces sp. International Chemical Congress of Pacific Basin Societies 2010 (PACIFICHEM 2010). Hawaii, USA, Dec., 2010.
11) Nishimura, S., Matsunaga, S., Kakeya, H., Yoshida, M. Mode of action of theonellamides, antifungal bicyclic peptides from a marine sponge. International Chemical Congress of Pacific Basin Societies 2010 (PACIFICHEM 2010). Hawaii, USA, Dec., 2010.
10) “c‘㈟ˆß, •ž•”–Ÿ, –p‹Ñ‰Ô, ŽR“cˆ€, ‘åÎ^–ç, “¡ˆäMF, Š|’JGº. ƒqƒg’Eƒ†ƒrƒLƒ`ƒ“‰»y‘fUSP47‚̍y‘fŠw“I«ó‰ðÍ. 83‰ñ“ú–{¶‰»Šw‰ï‘å‰ïE‘æ33‰ñ“ú–{•ªŽq¶•šŠw‰ï”N‰ï‡“¯‘å‰ï: Biochemistry and Molecular Biology 2010 (BMB2010). 12ŒŽ, _ŒË, 2010.
9) ‘å–ì—TŽi, •ž•”–Ÿ, ã“c³“¹, ‰eŽRi, ‹g‹M’BŠ°, Š|’JGº. C7orf24/GGCT‚Ì“]ŽÊ‚ÍNF-Y‚É‚æ‚芈«‰»‚³‚ê‚é. ‘æ83‰ñ“ú–{¶‰»Šw‰ï‘å‰ïE‘æ33‰ñ“ú–{•ªŽq¶•šŠw‰ï”N‰ï‡“¯‘å‰ï: Biochemistry and Molecular Biology 2010 (BMB2010). 12ŒŽ, _ŒË, 2010.
8) Œ‘ºTˆê, ‰z’qƒŽq, —L“c—SŽq, ŒŽRW‹v, Œ‰i–ÎŽ÷, ‹g“c–«, Š|’JGº. ŠCŽYR^‹Û•šŽ¿theonellamide‚̍ì—p‹@˜‰ð–Ÿ. ‘æ60‰ñ“ú–{–òŠw‰ï‹ß‹EŽx•”‘‰ïE‘å‰ï. 10ŒŽ, ‘åã, 2010.
7) PŒ—Y‘Ÿ, ‘åÎ^–ç, “¡ˆäMF, Œ‘ºTˆê, •ž•”–Ÿ, Š|’JGº. •úü‹Û‚ª¶ŽY‚·‚éV‹KTGF-ƒÀƒVƒOƒiƒ‹“`’B‘jŠQÜ‚Ì’P—£E\‘¢‰ðÍ‚ƍ‡¬. ‘æ‚T‚Q‰ñ“V‘R—L‹@‰»‡•š“¢˜_‰ï. 9ŒŽ, Ã‰ª, 2010. [§—ãÜ‚ðŽóÜ]
6) —с@–L, ’†‘º‘ñ˜N, ‘哇Œ’Žu˜N, •ž•”³•œ, ’·“c—T”V, Š|’JGº. V‹KŒŒŠÇV¶‘jŠQ•šŽ¿‚̐¶‡¬ˆâ“`ŽqŒQ‚̃Nƒ[ƒjƒ“ƒO. 2010”N“xi‘æ25‰ñj“ú–{•úü‹ÛŠw‰ï‘å‰ï. 9ŒŽ, “Œ‹ž, 2010.
5) ‘å’΂³‚‚«, ‚{N–Ÿ, ‚”š‚Ђ³Ž}, Ž…Žj˜Y, ’·“c—T”V, •ž•”–Ÿ, Š|’JGº. V‹K’áŽ_‘f—U“±ˆöŽq(HIF)‘jŠQÜ‚Ì‘n»Œ€‹†. ‘æ1‚S‰ñ“ú–{‚ª‚ñ•ªŽq•W“IŽ¡—Êw‰ïEŠwpW‰ï. 7ŒŽ, “Œ‹ž, 2010.
4) ‚{N–Ÿ, ‚”š‚Ђ³Ž}, •ž•”–Ÿ, Š|’JGº. V‹Kscaffold‚ð—L‚·‚éTGF-ƒÀƒVƒOƒiƒ‹“`’BŽÕ’f–ò‚Ì‘n»Œ€‹†. ‘æ1‚S‰ñ“ú–{‚ª‚ñ•ªŽq•W“IŽ¡—Êw‰ïEŠwpW‰ï. 7ŒŽ, “Œ‹ž, 2010.
3) Œ‘ºTˆê, ‰z’qƒŽq, —L“c—SŽq, ŒŽRW‹v, Œ‰i–ÎŽ÷, ‹g“c–«, Š|’JGº. ƒXƒeƒ[ƒ‹‚ð•W“I‚Æ‚·‚étheonellamide‚̍ì—p‹@˜‰ðÍ. “ú–{ƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[Šw‰ï ‘æ5‰ñ”N‰ï. 5ŒŽ, _“ސì, 2010.
2) Ohno, Y., Hattori, A., Ueda, M., Kageyama, S., Yoshiki, T., Kakeya, H. Involvement of NF-Y in transcriptional regulation if the human C7orf24/GGCT gene. Organisation for Oncology and Translational Research (OOTR) 6th Annual Conference. Kyoto, Japan, Feb., 2010. [—DGƒ|ƒXƒ^[”­•\Ü‚ðŽóÜ]
1) ‚{N–Ÿ, •ž•”–Ÿ, Š|’JGº.@V‹KŠÌŽŸŠ³Ž¡—Öò‚ÌŠJ”­Œ€‹†FhHit to Probeh‚̐헪‚ÆŽÀØ. uTGF-ƒÀŠˆ«‰»”œ‰ž‚ð•W“I‚Æ‚µ‚œŠÌŽŸŠ³‚̐V‹Kf’f–@, Ž¡—ÁE—\–h–@‚ÌŠJ”­vŒ€‹†”ǃVƒ“ƒ|ƒWƒEƒ€. 2ŒŽ, ‘åã, 2010.

2009


7) ‰Á“¡’ŒŽ÷, ‚–ØŠC, Š|’JGº, ’·“c—T”V. Aspergillus fumigatus‚É‚š‚¯‚épseurotin¶‡¬ˆâ“`ŽqƒNƒ‰ƒXƒ^[‚̉ðÍ. ‘æ9‰ñŽ…ó‹Û•ªŽq¶•šŠwƒRƒ“ƒtƒ@ƒŒƒ“ƒX. “Œ‹ž, 11ŒŽ, 2009.
6) Nishimura, S., Matsuyama, A.., Yoshida, M., Matsunaga, S., Kakeya, H. Regulation of sterol localization revealed by chemical genetics using theonellamide. The 5th International Fission Meeting. Tokyo, Oct. 2009.
5) Š|’JGº. ƒVƒ“ƒ|ƒWƒEƒ€uƒQƒmƒ€–ò—Šw‚Æ‘n–òvFƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[Œ€‹†‚ðŠî”Õ‚Æ‚µ‚œƒAƒJƒfƒ~ƒA‚É‚š‚¯‚é‘n–òŒ€‹†. ‘æ68‰ñ“ú–{ŠàŠw‰ïŠwp‘‰ï. ‰¡•l, 10ŒŽ, 2009iµ‘ҍu‰‰j.
4) Œ‘ºTˆê, ŒŽRW‹v, Œ‰i–ÎŽ÷, Š|’JGº, ‹g“c–«. ƒXƒeƒ[ƒ‹‚ð•W“I‚Æ‚·‚étheonellamide—Þ‚ª—U“±‚·‚镪—ôy•ê‚ÌŒ`‘Ԉُí. y•êˆâ“`ŠwƒtƒH[ƒ‰ƒ€‘æ42‰ñŒ€‹†•ñ‰ï. ’}”g, 7ŒŽ, 2009.
3) ‘å–ì—TŽi, •ž•”–Ÿ, Š|’JGº. V‹KŠàŠÖ˜AˆöŽqƒqƒgC7orf24‚Ì“]ŽÊ§Œä‹@\‚̉ðÍ. ‘æ13‰ñ“ú–{Šà•ªŽq•W“IŽ¡—Êw‰ï. “¿“‡, 6ŒŽ, 2009.
2) •ž•”–Ÿ, PŒ—Y‘Ÿ, ‘å’ˎѐD, ‚{N–Ÿ, Œ‘ºTˆê, –î‘q“O, ‘åÎ^–ç, “¡ˆäMF, Ž…Žj˜Y, ’·“c—T”V, Š|’JGº. HIF-1‹@”\§Œä‰»‡•š‚Ì•]‰¿Œn\’z‚Æ’TõŒ€‹†. “ú–{–òŠw‰ï‘æ129”N‰ï. ‹ž“s, 3ŒŽ, 2009.
1) Kakeya, H. Natural products-initiated chemical biology. Organic Chemistry Seminar in University of Louis Pasteur. Strasbourg, France, Apr. 2009 (Invited Lecture).

2008


5) Š|’JGº. ”÷¶•šŽ‘Œ¹‚ðŠî”Õ‚Æ‚µ‚œƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[Œ€‹†. ‘æ17‰ñ“V‘R–ò•š‚ÌŠJ”­‚Ɖž—pƒVƒ“ƒ|ƒWƒEƒ€. ƒVƒ“ƒ|ƒWƒEƒ€1\u”÷¶•šöÝ”\—͂̍ĔFŽ¯-‘n–ò‚ÆŠî‘bŒ€‹†‚ւ̉ž—pv. ”Ž‘œ, 11ŒŽ, 2008.iµ‘ҍu‰‰j
4) –î‘q“OAŠ|’JGºAˆÉ“¡”üç•äA–{‘œ‹`º. ’Ÿ‚̍‹C¬•ª¶¬‚ÉŠÖ—^‚·‚éƒeƒ‹ƒyƒ“‡¬y‘fˆâ“`Žq‚̉ðÍŒ€‹†. ‘æ55‰ñ“ú–{¶–òŠw‰ï”N‰ï. ’·è, 9ŒŽ, 2008.
3) —Ñ—Y“ñ˜YA¯Ži–žAÎì—ElAŽRŒûˆê˜YA“c‘º—F—TA¡ˆä_‹MAŒƒ–’J—m•ãA‚•”Œ«ˆêAŠ|’JGºA’·“c—T”V. ƒAƒ“ƒTƒ}ƒCƒVƒ“ŒnRŽîᇓV‘R•šAƒTƒCƒgƒgƒŠƒGƒjƒ“A‚Ì‘S‡¬. ‘æ50‰ñ“V‘R—L‹@‰»‡•š“¢˜_‰ï. ”Ž‘œ, 9ŒŽ, 2008.
2) Š|’JGº. "‚à‚Ì‚Æ‚è"‚ðŠî”Õ‚Æ‚µ‚œƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[Œ€‹†. ‘æ128‰ñ“ú–{–òŠw‰ïƒVƒ“ƒ|ƒWƒEƒ€ “V‘R•šƒpƒ[Fw‚à‚Ì‚Æ‚èC‡¬C‹@”\‰ð–Ÿx`‘åŠw”­“V‘R•š–òŠwŒ€‹†`. ‰¡•l, 3ŒŽ, 2008.iµ‘ҍu‰‰j
1) Š|’JGº. ‘n–òƒV[ƒYŠJ”­‚ðŽwŒü‚µ‚œV‹K“V‘R—L‹@‰»‡•š‚ÌŠJ‘ñE‘n»‚ƃPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[Œ€‹†. \S‘ŸEŒŒŠÇ•aŽ¡—Ẫ‹ƒlƒbƒTƒ“ƒX\—Տ°SŒŒŠÇÄ¶Œ€‹†‰ï. ‹ž“s, 1ŒŽ, 2008.iµ‘ҍu‰‰j

2007


@@@@@
6) Š|’JGº. —L—p“V‘R—L‹@‰»‡•š‚ÌŠJ‘ñ‚ƃPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[Œ€‹†. —L‹@‡¬‰»Šw‹Š‰ïuK‰ïi•œ¬19”N“xŒãŠúiHjj. “Œ‹ž, 11ŒŽ, 2007.iµ‘ҍu‰‰j
5) _ŽR—m, Š|’JGº, ‰PˆäŒ’˜Y, ŸNˆäG–Ÿ, ’·“c—T”V. Epoxyquinol B inhibits the NF- B signaltransduction pathway through the TAK1 activity. ‘æ66‰ñ“ú–{ŠàŠw‰ï. ‰¡•l, 10ŒŽ, 2007.
4) ŒàV³–F, ŽRŒûˆê˜Y, ¯Ži–ž, Š|’JGº, ¬–쐣—˜Œb, ’·“c—T”V. Panepophenatnrin‚Ì•sÄ‘S‡¬‹y‚Ñ‚»‚̍\‘¢Šˆ«‘ŠŠÖŒ€‹†. ‘æ49‰ñ“V‘R—L‹@‰»‡•š“¢˜_‰ï. ŽD–y, 9ŒŽ, 2007.
3) ‰Á“¡’ŒŽ÷A‚–ØŠCAóŒ©sOAŠ|’JGºA’·“c—T”V. Aspergillus fumigatus‚̐¶ŽY‚·‚é×–EŽüŠú‘jŠQÜƒgƒŠƒvƒƒXƒ^ƒ`ƒ“‚̐¶‡¬ˆâ“`ŽqƒNƒ‰ƒXƒ^[‚Ì“¯’è. ‘æ2‰ñ“ú–{ƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[Œ€‹†‰ï. ‹ž“s, 5ŒŽ, 2007.
2) Kakeya, H., Kamiyama, H., Osada, H. Chemical biology of epoxyquinol B, an anti-angiogenic small molecule. RIKEN International Symposium on Chemcial Biology 2007 (RIKEN ISCB 2007). Kanagawa, Japan, Jan., 2007.
1) Hayashi, Y., Matsuzawa, M., Yamaguchi, J., Shoji, M., Kakeya, H., Onose, R., Osada, H. Total synthesis and structure activity relationship of (+)-panepophenanthrin, a ubiquitin-activating enzyme inhibitor. The Takeda Science Foundation Symposium on Pharma Sciences: On the Frontiers of Chemical Biology. Tokyo, Japan, Dec., 2007.